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1. INTRODUCTION 
Aging causes 100.000 people deaths per day and 40 
million per year worldwide. It is responsible for 70 % of 
all human deaths (90 % in developed countries like Spain). 
The terrible degenerative diseases most cancers and 
cardiovascular diseases, senile dementias including 
Alzheimer disease, Parkinson´s disease, osteoporosis, or 
type-2 diabetes have a common root: aging. Even if some 
can survive one of these illnesses, another one will come 
rather soon because the body is old and thus heavily 
damaged. The large majority of human cancers will never 
ABSTRACT: The updated mitochondrial free radical 
theory of aging (MFRTA) is reviewed as part of the cell 
aging regulatory system (CARS). Any valid theory of 
aging should explain why different animal species age at 
so different rates. Only two known parameters correlate 
with species longevity in the right sense: the 
mitochondrial rate of reactive oxygen species 
production (mitROSp) and the degree of fatty acid 
unsaturation of tissue membranes calculated as the 
double bond index (DBI). Both are low in long-lived 
animals. Dietary restriction (DR), which increases 
longevity, also decreases mitROSp and % free radical 
leak (FRL) at complex I and oxidative damage to 
mtDNA. This can increase longevity by decreasing 
mtDNA fragments accumulation inside nuclear DNA 
which revitalizes MFRTA. Lowered mitROSp and FRL 
at complex I also occurs during protein or methionine 
restriction, and rapamycin treatment (which also 
increases longevity). The decrease in mitROSp during 
DR (dietary restriction) is due to restriction of a single 
substance, methionine, and occurs at the matrix domain 
of complex I. This updated MFRTA focuses on low 
mitROSp and low sensitivity of membranes to oxidation 
in long-lived animals. The three best known aging 
effectors of the genetic Aging Program of aerobic 
tissues are mitROSp, membrane fatty acid unsaturation, 
and autophagy. This program reacts to cytoplasmic 
signaling proteins, influenced by nutrients, drugs and 
hormones, varying the activity of the mitROSp and 
macroautophagy aging effectors. An analogous 
program, although with additional gene clusters of aging 
involved, and different output activity, can determine 
longevity in different animal species. 
RESUMEN: Se revisa la teoría del envejecimiento por 
radicales libres de origen mitocondrial (MFRTA) como 
parte del Sistema de Regulación Celular del 
Envejecimiento (CARS). Cualquier teoría del 
envejecimiento debe explicar porqué las especies 
animales envejecen a velocidades tan diferentes. Solo 
dos parámetros conocidos correlacionan con la 
longevidad de las especies en el sentido correcto: la 
producción mitocondrial de radicales de oxígeno 
(mitROSp) y el grado de insaturación de los ácidos 
grasos de las membranas celulares. Ambos están 
disminuidos en las especies longevas. La restricción 
calórica, de proteínas, o de metionina, y la rapamicina, 
que aumentan la longevidad, también disminuyen la 
mitROSp y la fuga % de radicales libres en el complejo 
I y el daño oxidativo al ADNmt. Esto puede aumentar la 
longevidad disminuyendo la acumulación de fragmentos 
del ADNmt dentro del ADN nuclear con la edad, lo cual 
revitaliza la MFRTA. El descenso en mitROSp durante 
la restricción calórica se debe sólo a la restricción de 
metionina, y ocurre en el dominio de membrana del 
complejo I. La mitROSp, el grado de insaturación de los 
ácidos grasos, y la autofagocitosis son los tres efectores 
de envejecimiento conocidos dependientes del programa 
genético pro-envejecimiento (PAP, que es parte del 
CARS). El PAP responde a proteínas de señalización 
celular en función de la disponibilidad de nutrientes y 
hormonas en los medios ambiente e interno. Este 
programa, aunque con más clusters génicos del 
envejecimiento implicados, y con diferente intensidad 
efectora, podría ser responsable de la regulación de la 
longevidad de las distintas especies animales. 
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be eliminated unless aging is defeated. Treating all the 
degenerative diseases one by one will never eliminate 
them. However, defeating aging, all of them will be 
eliminated with a single manipulation. This will restart 
evolution of increasing longevity, which has been among 
the main causes of the great success of our species in the 
planet, from our last common primate ancestors, the early 
small Plesiadapiformes-like Purgatorius which lived only 
around 10 years, to the 122 years that we can live now at 
best, a 10 fold (1.000 %) life extension. In order to 
accomplish this major goal, that will free us from most of 
those terrible illnesses and restart our evolutionary path 
towards an even higher complexity, we must first 
understand what are the fundamental basic mechanisms of 
aging down to the cell level. Once we know these, the 
large capacity of modern molecular biology and 
pharmacological techniques will finally allow 
accomplishing the old dream of decreasing, for the first 
time in history, human aging rate. 
After truly decreasing aging rate, it will be possible in 
the future for human beings to reach e.g. 100 years with a 
biological age equivalent to that of a young person of 
today of 30 years of age ("only" around 3 fold lifespan 
extension). That would be properly called "healthy aging", 
which is clearly not the case for most human centenarians 
nowadays. The previous approach implemented in the past 
century, merely to protect many people from death but not 
from aging, increased the percentage of people that 
reached old age, so that they are alive but they are 
biologically old and therefore weak and with a ever 
increasing exponential chance of suffer sooner or later 
degenerative diseases and death. The result is the ever 
increasing percentage of aged people in our societies, 
generating an enormous load for social security and health 
care systems, and strongly increasing the proportion of 
fragile, disabled, and long time suffering old individuals in 
the population. Our aged societies and their high economic 
burden constitute the frequently called huge 
socioeconomic "aging problem". All this can be solved by 
progressively attaining negligible senescence with the help 
of gerontological science. Biogerontology has the key to 
this solution that will help to propel humanity to a brighter 
future on its committed evolutionary path from simplicity 
to complexity, from dust to bacteria, to eukaryotic cells, to 
multicellular life, to better society, and then to new 
achievements that few can nowadays even wonder. 
Therefore, what causes aging? While many different 
theories of aging have been proposed, the mitochondrial 
free radical theory of aging (MFRTA) is one of the few 
current main explanations of aging and longevity in 
mammals, birds and multicellular animals in general. Any 
aging theory must explain why maximum longevity 
(referred here throughout as “longevity”) varies so widely 
in animals: 30 fold from mice to men, 200 fold from 
shrews to the longest-living whales, or more than 5,000 
fold from perhaps a few days of life in some invertebrates 
to Arctica islandica mussels (longevity around 500 years). 
Such huge differences indicate that longevity is markedly 
regulated and flexible during species evolution. Copying 
only a small fraction of this natural capacity would make 
possible in the future to reach negligible senescence in 
humans. Animals closely related by phylogeny, like Mus 
musculus (longevity 4 years) and Peromyscus leucopus 
(longevity 8 years) mice have very different maximum 
lifespans, indicating that evolution of longevity is also a 
relatively easy and quick process. Therefore, substantially 
decreasing the aging rate in mammals including humans 
will be relatively easy once the underlying basic 
mechanisms controlling longevity at physiological, cellular 
and molecular levels are elucidated.  
Mean lifespan and the life expectancy at birth of the 
individuals of a population depends more on the 
environment than on the genes. On the contrary 
(maximum) longevity, and its inverse -the species aging 
rate -, depends more than 90 % on the genotype, as it is 
also the case for any other species-specific trait. Longevity 
and aging rate are the parameters that matter concerning 
the endogenous process of aging. 
Up to now, only two known factors have demonstrated 
to correlate in the right sense with animal longevity in 
vertebrates including mammals and birds: a) the rate of 
mitROSp (mitochondrial reactive oxygen species 
production, Refs. 1-4); and b) the degree of fatty acid 
unsaturation (calculated as the double bond index, DBI) of 
tissue cellular membranes including the mitochondrial 
ones (5, 6). The longer the longevity of a species, the 
smaller the value corresponding to these two parameters. 
The low mitROSp of long-lived animal species decreases 
their generation of endogenous (free radical) damage at 
mitochondria. The low fatty acid DBI and peroxidizability 
index (PI) decrease the sensitivity of the cellular and 
mitochondrial membranes to free radical attack and lipid 
peroxidation. No other theory of aging focuses on 
parameters like these two, that correlate in the right sense 
with longevity across animal species (and also within 
single species), and offers plausible mechanistic 
explanations for the final accumulation of damage from 
endogenous origin leading to aging. This is relevant, since 
the most important fact that any theory of aging must 
explain is why longevity and aging rate vary so widely 
among different animals. 
2. ANTIOXIDANTS AND LONGEVITY 
Studies about MFRTA first focused in antioxidants, 
mainly because they could be measured with rather simple 
methods. In 1993 it was found at my laboratory that both 
enzymatic and non-enzymatic endogenous tissue 
antioxidants, including superoxide dismutase, catalase, 
GSH-peroxidases, GSH-reductases, GSH, or ascorbate, 
strongly correlated with longevity across vertebrates. 
However, and rather surprisingly, such correlation was 
negative, instead of positive as it was until that time widely 
believed. Our review on the relationship between 
endogenous antioxidants and vertebrate longevity (7) 
included all the available published data on the subject 
obtained in vertebrates including mammals by my as well 
as other laboratories. 
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Figure 1. Production of ROS at mitochondria (A) negatively correlates with longevity across animal species. Evolutionarily, this is 
the cause of the very low endogenous antioxidant (including antioxidant enzymes) levels of long-lived animal species (B). In addition, it 
nowadays mechanistically causes the low level of mtDNA oxidative damage of long-lived animals (C). (Refs. 7,20,23,29). 
All those data, coming from various different sources 
consistently agreed: the longer the longevity, the lower 
were the levels of most endogenous tissue antioxidants and 
antioxidant enzymes. A later reappraisal of the subject (8) 
confirmed the existence of a generally negative correlation 
between tissue antioxidants and longevity in all kinds of 
vertebrate animals (Figure 1A). It was most interesting that 
long-lived animals had lower instead of higher antioxidant 
levels. Among 27 studied correlations, 21 negatively 
correlated with longevity, six did not show significant 
differences, and not a single positive correlation with 
longevity was found (7). Superoxide dismutase was among 
the antioxidants tending to show no association with 
longevity. Previous believe that this enzymatic activity 
was positively associated with longevity was due to 
referring the SOD activity values (total SOD, CuZn plus 
Mn) to the oxygen consumption (VO2) of the whole 
animal (to the weight-specific metabolic rate). Since 
weight-specific metabolic rate strongly decreases as body 
size increases, the larger SOD/VO2 of humans compared to 
rats was due to the lower value of the denominator in the 
humans (lower weight-specific metabolic rate than rats) 
instead of to a higher value of the numerator (SOD). In 
fact when the tissue SOD values (total SOD, CuZn plus 
Mn, without dividing by VO2) were plotted against 
longevity across species they showed no significant 
correlation with mammalian longevity in mammals in the 
original publication (9). In the brain and lung of vertebrate 
species –but not in liver- the correlation between SOD 
(total SOD, CuZn plus Mn) and longevity was again 
negative like for the other antioxidants. Further studies in 
different mammals including long-lived naked mole-rats, 
as well as ants, honey bees and marine bivalves also found 
a negative correlation with longevity for this antioxidant 
enzyme –SOD (8). In this more recent and comprehensive 
review of the subject, among a total of 78 correlations 
between endogenous tissue antioxidants and longevity, 72 
were negative, six did not show significant differences, 
and only a single one was positive (8), corroborating 
global studies performed almost two decades ago (7). 
Therefore endogenous antioxidant levels are clearly not 
the cause of the high longevity of long-lived animal 
species.  
3. MITOCHONDRIAL ROS GENERATION, mtDNA 
OXIDATIVE DAMAGE, AND LONGEVITY  
3.1. Comparative studies of mitROSp 
Why long-lived animals need less antioxidant levels in 
their vital organs? We proposed (10) that the rate of 
mitROSp could be negatively correlated with longevity and 
that this would be the critical factor for aging, instead of 
the antioxidants. Long-lived animals would not need to 
maintain high antioxidant enzyme levels, which is 
energetically expensive, because they would produce 
mtROS at a low pace, and they could transitorily induce 
them if needed. This was indeed experimentally 
corroborated comparing mammalian species with different 
longevities (3) (Figure 1B) as well as comparing short-
lived rodents (rats and mice) with 8 fold longer lived birds 
(pigeons, parakeets and canaries) of similar body size and 
weight-specific metabolic rate (11, 12). A posterior 
investigation studying up to 12 different mammalian 
species confirmed these findings even after correcting for 
body size (4). 
The studies in birds are especially important because 
the studies performed in mammals used species following 
the Pearl rate of living law of aging: “the lower the weight-
specific metabolic rate the longer the longevity”. Thus, one 
could not discard, in principle, the possibility that the 
species with longer longevity included in the comparisons 
between different mammals could show low rates of 
mitROSp simply because their rates of oxygen 
consumption were also lower than those of the short-lived 
ones. In fact mitROSp was positively correlated with 
mitochondrial O2 consumption and with global metabolic 
rate in those studies (3). It was then important to study the 
problem in some of the many species that deviate from the 
Pearl´s rate of living law (an old theory of aging ruled out 
long ago). Three groups of warm-blooded vertebrates have 
much higher longevity than expected for their body size or 
weight-specific metabolic rate compared to most 
mammals: birds, bats and primates. Birds have both a 
high rate of oxygen consumption per gram of tissue and a 
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high longevity. This makes them ideal to solve the 
problem mentioned above. The lower mitROSp of 
pigeons, canaries and parakeets, when compared to rats in 
the first case and to mice in the second and third case, 
strongly reinforces the MFRTA since it indicates that the 
low mitROSp of long-lived animals occurs both in 
comparisons between animals following Pearl´s law as 
well as in those not following it. A high longevity is not a 
simple consequence of a slow rate of living. It can be 
obtained –as the bird case shows- together with high rates 
of oxygen consumption and animal aerobic activity. High 
longevity in the studied birds is associated with a low rate 
of mitROSp both in absolute terms, and also as percentage 
of mitochondrial oxygen consumption and thus of electron 
flow at the electron transport chain (birds have a low 
percent free radical leak, FRL). 
3.2. The mitROSp site at the ETC important for longevity 
It was been widely believed for decades that complex 
III of the respiratory chain was the respiratory complex 
responsible for ROS production in the ETC (the 
mitochondrial electron transport chain) (13). Later it was 
found, already working with freshly isolated and well 
coupled functional mitochondria, that complex I also 
produces ROS in heart or brain mitochondria isolated from 
rats, mice, pigeons, canaries and parakeets (12, 14), which 
was soon confirmed in rats by other laboratories (15, 16) 
and soon became established knowledge in biochemistry 
books.  
A key experiment to detect complex I ROS production 
was to measure mitROSp with succinate alone as well as 
with succinate+rotenone. In the second situation the rate of 
mitROSp acutely decreases because rotenone does not 
allow the electrons to flow back to complex I from 
succinate-complex II through reverse electron flow (17). 
But the habitual procedure of adding succinate alone, 
followed or not by antimycin A, and rarely using complex 
I-linked substrates, led to the general but erroneous believe 
during decades that mitROS came mainly from complex 
III-semiquinone. 
In addition, we also found that the lower mtROS 
generation rate observed in birds compared to mammals of 
similar body size and weight-specific metabolic rate 
occurred only at complex I (12, 14, 17), not at complex III. 
This is most interesting since we found the same 
afterwards in dietary restriction (DR) rat models (see 
section 5). Concerning the precise site within complex I 
where ROS are produced three generators have been 
suggested, the flavin at the beginning of the electron path 
within the complex, the FeS clusters of the hydrophilic 
matrix domain, and the ubiquinone located in the 
membrane domain. Various investigators have supported 
the role of the flavin based on experiments with the 
inhibitor diphenyliodonium, which strongly decreases 
mitROSp. However, the site of action of 
diphenyliodonium, at the beginning of the electron path, 
also avoids electrons to reach the other two possible 
generators, the various FeS clusters and the ubiquinone, 
which therefore can not be discarded in those experiments. 
In other investigations, it was concluded that electron leak 
to oxygen occurred between the ferricyanide reduction site 
and the rotenone binding site of Complex I both in intact 
mitochondria (12, 14, 17) as well as in submitochondrial 
particles (18). Iron-sulphur clusters with a higher midpoint 
potential than FeSN1a, which could be situated in the 
electron path after the ferricyanide reduction site (15,18), 
or the unstable semiquinone known to be present in the 
membrane domain of Complex I and possibly functioning 
in H+ pumping coupled to electron transport (19), could be 
the complex I oxygen radical generators. However, many 
different Complex I FeS clusters could be responsible for 
complex I mitROSp because, under physiological 
conditions: (a) their reduced and oxidized states will not be 
present in equal concentrations; (b) interactions with many 
different factors and surrounding macromolecules could 
modify the final redox potential of the carriers in vivo; and 
(c) the exact position of many FeS clusters in the Complex 
I electron path is still unknown. Thus, the important aging-
related question whether flavin, FeS clusters or 
ubisemiquinone, or a combination of these, are responsible 
for the complex I ROS generation relevant for aging was 
still unanswered (but see the proteomics ETC study 
described at section 5, Ref. 53). 
3.3. Oxidative damage to mtDNA and longevity 
The location where mitochondrial DNA (mtDNA) is 
situated is very close to the site of mtROS generation, the 
ETC at the inner mitochondrial membrane. ROS 
production also occurs at other cellular sites like 
microsomes, peroxisomes or membrane-bound NADPH-
oxidases, and the rate of ROS generation at those sites can 
substantially exceed in various situations that coming from 
mitochondria. However, the ROS produced at 
mitochondria can be still the most important ones for 
longevity due to the presence of mtDNA within the 
mitochondria but not at those other organelles or parts of 
the cell. Since long-lived animal species have low rates of 
mtROS generation, it was logical to expect that this should 
have an effect on the steady-state level of oxidative 
damage in their mtDNA. Therefore we decided to measure 
the level of 8-oxodG (8-oxo-7,8-dihydro-
2’deoxyguanosine) in the heart and brain mitochondrial 
and nuclear DNA of eight different mammalian species 
differing by up to 13-fold in longevity. The results showed 
that the level of 8-oxodG in the mtDNA of both organs is 
negatively correlated with longevity (20). The longer the 
longevity of a species, the smaller is its mtDNA oxidative 
damage degree (Figure 1C). In contrast, the 8-oxodG level 
in nuclear DNA (nDNA) did not correlate with longevity 
in any organ even though mitochondrial and nuclear DNA 
was measured in the same samples taken from the same 
individual animals (20). Therefore, the different mitROSp 
rates of the different species seem to have a direct impact 
on mtDNA, and not on nDNA, concerning oxidative 
damage. This makes sense since the site of ROS 
generation at mitochondria is very close to mtDNA 
whereas nDNA is situated far away from it inside the 
nuclear compartment.  
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The rate of mitROSp is measured in isolated 
mitochondria in vitro due to the lack of reliable methods 
for direct in vivo mitochondrial H2O2 production 
determination. However, since the variations in the steady-
state levels of 8-oxodG in mtDNA closely reflect the 
variations in the rate of mitROSp, both in comparative 
(Figure 1B,C) and in dietary restriction (DR; section 5) 
studies, suggests that the mitROSp in vitro measurements 
were closely indicative of the situation in vivo. In addition, 
the level of 8-oxodG in mtDNA was generally lower in the 
heart and brain of three long-lived birds when compared to 
two short-lived mammals of similar body size and specific 
metabolic rate, in agreement with the superior longevity of 
the birds, whereas again this was not the case for nDNA 
(21). These investigations also showed that the intensity of 
oxidative damage is several fold higher in mtDNA than in 
nDNA in the heart and brain of all the 11 different species 
of mammals and birds studied (20, 21), which is again 
consistent with the close proximity between mtDNA and 
the sites of mtROS generation. Studies on the longest- 
lived metazoan, the bivalve A. islandica have also shown 
increases with age in DNA oxidation and lower DNA 
oxidative damage than in other bivalve populations with 
much shorter (6 fold lower) longevities (22). 
3.4. Increasing antioxidants does not change longevity 
Initial studies about MFRTA were mainly focused on 
antioxidants because they were easier to measure, and 
because sensitive enough techniques to assay mitROSp in 
different species were generally not available at that time 
mainly due to the generalized use of spectrophotometry 
instead of fluorometry. Most of the investigations on the 
effect of adding dietary antioxidants to the diet were 
performed during the 1970´s and 80´s. The general result 
was that antioxidants did not increase (maximum) 
longevity (23, 24). In some experiments they increased 
only mean longevity (23-25). Interestingly, this tended to 
occur when the (maximum) longevity of the control 
rodents was short, usually less than 3 years. This suggests 
that antioxidants, when the husbandry conditions are 
suboptimal, could protect from causes of early death, and 
thus they can make more rectangular the survival curve. 
This is what happened in humans during the XXth century 
in many developing western countries when mean life 
expectancy increased from around 40 to 80 years without 
decreasing in aging rate. That is why now the old are so 
abundant in western populations. Antioxidants, in such 
cases above, were bringing back towards optimum the 
diminished survival of the controls reared under 
suboptimum environmental conditions, which is 
interesting but not the goal of gerontology. Ironically, the 
poorer the survival curve of the controls, the largest is the 
chance of obtaining a positive result in terms of mean 
longevity. A most inappropriate stimulus to not well done 
research indeed. Whereas, the better one performs the 
experiment, the less chances one has of obtaining an 
increase in mean longevity. In summary, like in the 
comparative inter-specific studies described above, 
antioxidants clearly can not be among the factors 
responsible for low aging rates and high (maximum) 
longevities.  
When the techniques to obtain transgenic or knockout 
mice with increased or lack of expression of genes 
codifying for antioxidant enzymes like SODs, catalase, or 
GSH-peroxidases, were applied to this problem, the results 
were (obviously) similarly disappointing (26, 27). The 
antioxidant enzyme activities increased through 
modification of gene expression, like the non enzymatic 
dietary antioxidants added to the diet, did not slow aging. 
Independently of the way in which the antioxidants were 
manipulated, dietary or genetic, the result was the same: a 
lack of effect of antioxidants on mammalian longevity. 
This has been interpreted by some (27) but not other (28) 
authors as the “death” of the MFRTA (27), but such 
conclusion (27) did not take into account that what 
correlates with longevity in the right sense is not the level 
of the antioxidants, but the mitROSp rate and the fatty acid 
unsaturation degree of the cellular membranes (23, 29). 
Studies in simpler organisms like the fungus 
Podospora anserina have provided strong evidence for a 
role of mitROSp in senescence including DR-effects, and 
strains of this fungus deprived of mitROSp are converted 
to "eternal" non aging organisms (30). Recent experiments 
in 29 different longevity mutants, and 26 different 
environmental situations and drugs that increase (DR, PR, 
MetR, rapamycin, starvation, and others) or decrease 
(including 10 or 20 mg/l glucose medium, the 10µM 
amyloid-binding compound ThT, 1mM 4,4´-
diaminodiphenylsulphone DDS, 10 mM N-acetyl cysteine) 
longevity used a new fluorescent probe claimed to estimate 
mitROSp (“free radical production and metabolic activity 
at the single-mitochondrion level”, Ref. 31) for the first 
time in vivo. The results of these studies, performed in the 
nematode worm C. elegans, were extremely interesting. In 
all the 55 cases lower "mitROSp" (mitoflash) was always 
observed in log-lived animals (31). These results were 
quickly and heavily criticized in the same journal (Nature) 
by 27 other researchers from different fields related or not 
gerontology. The critics claimed that what the mitoflash 
technique estimated was not mitROSp (superoxide radical) 
because changes in fluorescence of the cpYFP used (the 
sensor circularly permuted yellow fluorescent protein in 
the matrix) “are due to alterations in pH, not superoxide". 
Thus, the critic was exclusively methodological, and did 
not consider what could be the biological significance of 
Shen et al. results (31). The reply of the authors of the C. 
elegans mitoflash study was also published in Nature 
together with the critic. The authors of the mitoflash study 
have continued publishing further investigations since 
2014 using the same technique, leading to around a dozen 
further publications, some in mouse muscle, and in some 
studies they tried to ascertain if H+ indeed interfered or not 
with their mitoflashes. The issue does not seem still 
resolved today. But if the critics are correct, why then low 
mitoflash (as claimed partial estimator of "mROSp") was 
always observed in long-lived animals, in full agreement 
with hundreds of published mitROSp-longevity studies 
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summarized in the present review? How a probe reacting 
only to pH could consistently vary with longevity always 
in the right sense in 55 mutant or environmental longevity 
models? And most importantly, what is the hypothesis 
relating H+ to longevity? To the best of my knowledge 
none has been proposed. Perhaps proton gradient and 
mitochondrial membrane potential are indirectly related to 
longevity through changes in mitROSp, and this 
relationship would add to a possible reaction of some ROS 
with cpYFP. If this were true, both the critics and the 
authors of the study (31) would be right, and the 
impressive results would have a strong value for 
biogerontology. In any case, these important physiological 
questions have not been resolved and still wait for 
adequate answers. I consider most important to fully 
clarify this issue. The availability of a technique (mitoflash 
or any other better one?) that could reliably estimate how 
much mitochondrial ROS are produced in a mouse in vivo 
would be, no doubt, of paramount value for researchers 
and a most fundamental advance for gerontology.  
3.5. The Contact Hypothesis of Aging. mitROSp instead of 
defences or repair control aging  
Studies in mammals and other vertebrates clearly 
indicate beyond reasonable doubt that the rate of mitROS 
generation importantly contributes to determine longevity, 
whereas antioxidants do not (23, 24, 29, 32). This is 
counterintuitive only if we erroneously consider the cell as 
a homogeneous system without compartmentation. But 
cells are not like that. The global cellular level of oxidative 
stress should depend both on the rates of ROS production 
and ROS elimination. Both contribute to determine cell 
survival or cell death according to the general “balance” 
between them, and likely affect mean lifespan. However, 
the ROS concentration in particular compartments like 
mitochondria, and most especially very near to the places 
of mitROS generation like complex I, should be much 
more dependent on mitROSp than on antioxidants as the 
free radical generation site relevant for aging is 
approached at micro level. At such places, it is mitROSp 
what would mainly determine the local ROS concentration 
(Figure 2). This is especially important because the main 
target for aging, mtDNA, is located very close in the 
vicinity, perhaps even in contact with the free radical 
generation source.  
 
Figure 2. Low ROS local concentration near mtDNA in long-lived species. Long-lived animals show both low rates of mitROS 
production (Figure 1B) and low antioxidant levels (Figure 1A), and the reverse is true in short-lived-lived ones (7,10). Therefore, both 
kinds of animals have a similar and moderate level of mean oxidative stress (and H2O2 concentration) at most cellular sites. This is 
necessary for general cell homeostasis and survival both in animal species with high and low longevities. But the local concentration of 
ROS at the site of ROS production is much lower in long-lived than in short-lived species due to their low rates of mitROS production. 
This causes the lower oxidative damage to mtDNA (Figure 1C and Ref. 20) of long-lived species because mtDNA is situated nearby or 
even in contact with the site of ROS production at complex I relevant for aging. The model predicts the existence of a gradient of H2O2 
concentration from mitochondria to the surrounding cytoplasm. The size of the stars, lower in long-lived species, represents the local ROS 
concentration at the sites of mitROSp at complex I, which is lower in long-lived species. 
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This would explain why lowering the rate of mitROSp 
instead of increasing antioxidants was selected for during 
the evolution of longevity in mammals, birds, and other 
species. And it would be consistent with the view that 
mitochondria are causal players in the aging process. 
Contact between mtDNA and specific mitochondrial 
proteins agrees with classic electron microscopic studies 
(33). Mitochondrial nucleoid structure has been long 
debated, with an estimation of about 2-10 mtDNA 
molecules coated by an unspecified number of proteins 
(34). However, using high-resolution microscopy, the 
structure of the nucleoids has been further clarified as 
single mtDNA circular molecules compacted by 
mitochondrial transcription factor A (TFAM, 35), which 
forces mtDNA to undergo a U-turn, thus collapsing the 
mtDNA molecule.  
3.6. Low mitROSp, and then low endogenous antioxidant 
defences and DNA repair, in long-lived animals 
In order to decrease damage to mtDNA it is much more 
efficient to lower the rate of generation of damage than to 
have a higher rate of generation of damage and, 
afterwards, try to intercept the generated ROS using 
antioxidants, or try to repair the damaged already inflicted 
on mtDNA. This last approach would not make sense if 
generation of damage can be controlled on the first place. 
This is why long-lived species have not used high 
(antioxidant) defence (7,8,10,11,23,24,29,32) or high 
repair of endogenous DNA damage (reviewed in 29) to 
increase longevity. In addition, it would be very costly to 
continuously maintain high levels of antioxidant or repair 
enzymes in long-lived mammals to counteract a high rate 
of damage generation. Instead, lowering mitROSp: i) is 
much easier; ii) is 100 % efficient; and iii) avoids much 
damage at around zero cost. This view is fully consistent 
with the idea that aging is generated (evolutionarily 
speaking) "on purpose" by the organism itself, that aging 
has an adaptive value, likely for the group (2), and 
possibly to speed up evolutionary pace because it increases 
diversity and thus evolvability (2). This is why it has been 
selected for during evolution and programmed in the 
genotype to be expressed at widely different rates in 
agreement with the fecundity, population size, and many 
other traits of each particular species on its ecological 
niche (see section 9.2). The association between fecundity 
and longevity is not physiological, as the Disposable Soma 
Theory of aging assumes without evidence and lacking any 
physiologically plausible mechanism that could support it, 
but genetic. Because fecundity must be necessarily linked 
to longevity in the cell Aging Program (see section 9), 
otherwise population size would oscillate too much 
endangering the survival of the group. 
3.7. FRL is not a constant percent, and mitROS are not 
simple "by-products", of the ETC 
The fact that mitROSp is low in long-lived species 
irrespective of the value of their specific metabolic rate is 
clearly against the common belief that mitROS production 
is an unavoidable "by-product" of the respiratory chain. 
Mitochondria can vary the percentage free radical leak 
(FRL = % mitROSp/mitO2 consumption) in the respiratory 
chain. They decrease such percentage (the FRL) in 
especially long-lived animals, like birds or dietary 
restricted rats. They lower the FRL to decrease mitROSp 
(to age slowly), while their mitochondrial oxygen 
consumption is not depressed to be able to continue 
mitochondrial ATP generation at the rates needed for the 
normal activity level of the animal. If ROS leakage were 
an "unavoidable by-product" of the mitochondrial electron 
transport chain, the FRL would be a rather constant % of 
electron flux at the ETC. Instead, the FRL is decreased 
especially long-lived animals like birds, that live 2-3 fold 
longer than mammals of the same body size and specific 
metabolic rate. Contrarily to the "by-product" unproven 
heavily repeated assumption, mitROSp is finely tuned 
(regulated) in each animal, and if necessary, it varies 
independently of the rate of mitochondrial oxygen 
consumption and the total rate of electron flow at the ETC. 
Thus, the FRL varies in many cases to contribute to 
determine the aging rate and the longevity of the species 
(birds), or the individual (during the DRs). The lazy 
assumption currently present in too many scientific articles 
that mitROS are "unavoidable by-products of the ETC" 
should be avoided because the measurements on functional 
isolated mitochondria data have demonstrated it to be false 
on too many occasions. The use of this "by-product" 
concept should be exclusively limited to particular 
situations on which it is known to be correct, but not as a 
generalization for every situation. This is important 
because this wrong concept is making enormous damage 
to the scientific gerontological advance concerning 
MFRTA, and therefore towards solving the aging problem. 
4. LONGEVITY AND MEMBRANE FATTY ACID 
UNSATURATION 
In addition to mitROSp, there is a second known 
parameter that also correlates with longevity in the right 
sense, the fatty acid unsaturation degree of tissue cellular 
(including mitochondrial) membranes. This is also well 
known since it has been studied many times in more than 
20 well controlled different investigations and concordant 
results were always obtained. The degree of fatty acid 
unsaturation can be summarized as the double bond index 
(DBI), or alternatively, as the peroxidizability index (PI). 
The longer the longevity of the species, the smaller the 
total number of tissue fatty acid double bonds (the smaller 
the DBI, Figure 3A, and PI). A constitutively low DBI 
strongly decreases the sensitivity of the cellular and 
mitochondrial membranes to lipid peroxidation, a highly 
destructive process. Lipid peroxidation, in addition to 
membrane damage, produces mutagenic and toxic 
metabolites. Peroxidation of lipids quantitatively is the 
most intense destructive process produced in cells by ROS. 
Fatty acids containing a high number of double bonds (like 
20:4n-6 and especially 22:6n3) are the cellular molecules 
most sensitive to lipid peroxidation, and their sensitivity to 
lipid peroxidation increases exponentially as the number of 
double bonds per fatty acid molecule increases. The low 
Mitochondrial ROS and mtDNA fragments inside nuclear DNA as a main effector of ageing: the “cell aging regulation system” 
@Real Academia Nacional de Farmacia. Spain 55 
DBI and PI of long-lived animals was first described in 
1996 in rat compared to pigeon and human mitochondria 
(36) followed by many studies in mammals and birds (see 
5,6 for review). A total of 23 studies extended the seminal 
first observation (36) to many different mammals, various 
bird species, and some invertebrates, without finding a 
single exception: low tissue DBI in long-lived animals (6). 
The low degree of fatty acid unsaturation occurs both in 
mitochondrial as well as in total cellular membranes in 
tissues of long-lived animals. It can therefore strongly 
diminish lipoxidation-derived damage in various cellular 
compartments, and especially in the mitochondrial one. At 
those organelles there is strong abundance of membranes 
together with a nearby and rather constant source of ROS 
during mitochondria respiration throughout the whole life 
span. 
 
Figure 3. Low degree of membrane fatty acid unsaturation in tissues of long-lived animal species. A) Double bond index (DBI) in 
the heart of 8 mammals with widely different longevities; B) Levels of the highly unsaturated docosahexaenoic acid (22:6n-3) in liver of 
8 mammals; C) Levels of the much less unsaturated linoleic acid (18:2n6) in liver of 8 mammals. DBI (and PI) (part A) and 22:6n-3 (part 
B) are low in long-lived animals, whereas 18:2n-6 is higher in long-lived ones (part C). In studies in some tissues or species low 20:4n-6 
and high 18:1n-9 are also typical of long-lived animals. Similar results were obtained in skeletal muscle, and in mitochondria from the 
three mammalian tissues. Three birds also showed lower DBI than mammals of similar body size. Reviewed in Refs. 5,6, and Physiol. 
Reviews 87:1175-213, 2007. 
Among the different fatty acids composing the 
different cellular membranes many are responsible for the 
strong decrease in DBI (and PI) as longevity increases 
among species. But the most important ones, both due to 
their content in double bonds (low or high) as well as for 
their larger quantitative presence and variation among 
species, are 18:2n-6, 18:3n-3 and 22:6n-3 in mammals 
(Figure 3B,C), and in some phylogenetic groups also 
18:1n-9 (at least in the studied birds) and 20:4n-6. As 
longevity increases across mammalian species tissue 
18:1n-9, 18:2n-6 (Figure 3C) and 18:3n-3 significantly 
increase, and 20:4n-6 and especially 22:6n-3 (Figure 3B) 
significantly decrease in skeletal muscle, liver, and heart 
cellular membranes. Among them, the decrease in 22:6n-3 
in long-lived animals usually is the most important to 
quantitatively explain their low DBI and PI values (Figure 
3A,B). Interestingly, the final result is that the total 
percentage of unsaturated and saturated fatty acids does 
not change among species with different longevities. 
Instead it is the unsaturation degree of the polyunsaturated 
fatty acids present what decreases from short- to long-lived 
animals. Long-lived animals have fatty acids with a lower 
degree of unsaturation, with less double bonds per fatty 
acid molecule. With this kind of fatty acid redistribution 
long-lived animals obtain a strong decrease in the 
sensitivity of their cellular membranes to the destructive 
and mutagenic process of lipid peroxidation, while likely 
avoiding strong changes in the fluidity of their membranes, 
the so called homeoviscous–longevity adaptation (5). In 
addition, it has been recently shown that feeding 18:1n-9 
reverses the increases in 20:4n-6 and 22:6n-3 and the 
decreases in 18:1n-9 and 18:2n-6 and complexes I and IV 
activities observed in the skeletal muscle of old rats (37). 
Recent confirmation of the low tissue fatty acid 
unsaturation of long-lived animals has been obtained 
through shotgun lipidomic analysis of mitochondrial 
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phosphatidylcholine, phosphatidylethanolamine, and 
phosphatidylserine in skeletal muscle, liver and brain of 
mammals with widely different longevities (38).  
The low DBI of long-lived animals likely protects not 
only the lipids but also other kinds of cellular components. 
Since lipid peroxidation is a relatively massive process 
compared to oxidative damage to other kinds of 
macromolecules, long-lived animals, due to their low DBI, 
will produce far smaller amounts per unit time of highly 
toxic and mutagenic lipid peroxidation products like 
hydroxynonenal, malondialdehyde, and many others. 
These, having carbonyl groups, can modify free amino 
groups in proteins and DNA. Lipid peroxidation-derived 
protein modification seems to be involved also in aging, 
since comparisons among different mammalian species 
have found that the amount of malondialdehyde-lysine 
adducts in heart proteins negatively correlates with 
longevity (39). 
What is the metabolic mechanism responsible for the 
negative correlation between the fatty acid unsaturation 
degree and species longevity? A role for 
acylation/deacylation of the constitutive membrane fatty 
acids can not be discarded. However, since the more 
unsaturated 20:4n-6 and 22:6n-3 are essential fatty acids 
synthesized from their dietary precursors 18:2n-6 and 
18:3n-3 respectively, the enzymatic processes that control 
the n-3 and n-6 biosynthetic pathways seem to be 
involved. In this respect, in various comparative studies 
relating the degree of fatty acid unsaturation to longevity 
the results suggest that desaturase and elongase enzymatic 
activities in the n-3 and n-6 series (which are rate limiting 
for those biosynthetic pathways) are constitutively low in 
long-lived animals. In some cases decreases in 
peroxisomal beta-oxidation could also be involved. It is 
now considered that this last process is responsible for the 
last steps in the synthesis of the highly unsaturated 22:6n-3 
in the n-3 pathway. The low delta-5 and delta-6 desaturase 
activities (which are rate limiting enzymes in the n-3 and 
n-6 fatty acid synthesis pathways) of long-lived animals 
will decrease the conversion of the less unsaturated 18:2n-
6 and 18:3n-3 diet-derived precursors to the highly 
unsaturated 20:4n-6 and 22:6n-3 products. Thus, 18:2n-6 
and 18:3n-3 would accumulate and 20:4n-6 and 22:6n-3 
will diminish, which is just the general kind of fatty acid 
profile observed in long-lived animals.  
In summary, the membrane fatty acid unsaturation 
degree is low in tissues of long-lived animals. This is the 
only other known factor, in addition to mitROSp, which 
correlates with longevity in the right sense. Importantly, 
this is true concerning the MFRTA as well as any other 
theory of aging. And the degree of fatty acid unsaturation 
suggests a plausible mechanism to contribute to the widely 
different aging rates of the different animal species. And 
what is the situation concerning experiments inducing 
increases in longevity in single mammalian species? 
5. DIETARY RESTRICTION 
It is well established that standard (40 %) dietary 
calorie restriction (DR) increases not only mean but also 
maximum longevity (up to 40 %) and decreases and delays 
the incidence of degenerative diseases in most animal 
species including rotifers, flies, spiders, worms, fish, 
laboratory rodents and many other mammals (40; Table 1). 
In a 20 years-long adult-onset study in rhesus monkeys 30 
% DR strongly decreased age-related mortality (from 37 % 
to 13 %), the incidence of many age-related diseases 
including diabetes, cancer, cardiovascular disease, and 
brain atrophy (41). Many effects of DR have been 
discovered involving lowered GH and insulin/IGF-1-like 
signalling, modifications in nutrition and amino acid-
sensing pathways, changes in sirtuins (42), apoptosis, and 
signalling proteins and transcription factors like 
mTOR,S6K, AKT, PKA, or FOXO and tissue-specific 
changes in gene expression profiles. Many of these 
changes and others are interrelated and seem to be part of 
an integrated cellular aging regulation system (see section 
9) which includes mitochondria oxidative stress-related 
damage, and sensitivity to lipid peroxidation, as two of its 
main aging effectors (42).  
In the previous sections it was described that long-lived 
animals have lower rates of mitROSp and lower mtDNA 
oxidative damage than short-lived ones (29). But what 
occurs in DR? If the MFRTA is correct also inside species, 
those two parameters should also decrease during DR. 
Initial studies, like in the case of the comparison between 
different species, focused mainly on antioxidants. They 
showed that DR in rodents does not lead to a generalized 
increase in antioxidants. Instead increases, decreases or 
lack of changes, depending on the particular antioxidant 
measured, have been reported even within the same study 
(43). Therefore, similarly to what happens in the inter-
species comparative case, the key to longevity again is not 
based on the antioxidants levels during DR.  
A different situation concerns mitochondrial ROS 
generation. The effect of DR on the rate of mitROSp was 
repeatedly investigated in mice, and especially in rats, by 
many different laboratories. The results of these 
investigations consistently agreed that long-term standard 
(40 %) DR, as well as short-term (e.g.: 7 weeks) DR, 
significantly decrease the rate of mtROS generation in rat 
organs including skeletal muscle, kidney, liver, heart and 
brain (44, Table 1). This agrees again with the concept that 
lowering mitROSp contributes to increase longevity. The 
decrease in mitROSp during DR was found in freshly 
isolated functional mitochondria exposed to similar 
incubation conditions, including the substrate 
concentration used to feed electrons to the ETC, in the ad 
libitum fed and DR groups. Thus, DR mitochondria are 
different from those obtained from ad libitum fed animals, 
and this difference (due to DR) is responsible for the 
lowered mitROSp detected in vitro. In addition, classic 
data suggest that complex I substrates like pyruvate 
decrease during DR in tissues (45), which has been 
recently confirmed by full metabolome analysis (46). The 
decrease in pyruvate and other mitochondrial substrates 
would decrease the in vivo matrix NADH level in DR thus 
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lowering electron feeding of complex I by NADH. This 
would in turn decrease the degree of electronic reduction 
of the complex I ROS generator, and then its rate of 
oxygen radical production. Indeed, DR also decreases the 
NADH concentration (45, 46), a change that is known to 
strongly decrease the rate of mitROSp (16). This will lead 
to a further decrease in the rate of mitROSp in vivo which 
would add to that due to the lowered capacity of DR 
mitochondria to generate ROS detected in vitro. 
Interestingly, the decrease in mitROSp in DR rats 
specifically occurred at complex I in all the organs studied 
(47-49). Thus, a low rate of mitROSp at complex I is a trait 
both of long-lived species and of DR mammals. A recent 
study showed that a single nucleotide mutation in complex 
I suppresses mouse fibroblast aging (50), and inhibition of 
this complex by the antihyperglycemic and proposed 
antiaging modulators biguanides lowers its rate of 
mitROSp (51). Many studies have shown that 
mitochondrial functionality and even morphology is 
detrimentally altered in tissues of old animals (52). 
Recently, proteomic analysis of 57 out of the 96 known 
mouse ETC proteins (and 67 % of complex I proteins), 
showed that low abundance of the "matrix domain-only" of 
complex I, independent from the rest of the complex, 
lowers mitROSp and is related to increased longevity both 
in DR and in longer-lived mouse strains, while it increases 
during mouse aging (53). That is highly interesting since 
we and others have located the ROS generator relevant for 
aging precisely inside that matrix domain of complex I, and 
likely corresponds to one of the FeS clusters of that 
domain (15,18,47). 
 Dietary restriction, in addition to lowering mitROSp, 
also decreases the FRL (Table 1). This indicates that the 
efficiency of the mitochondrial respiratory chain in 
avoiding ROS generation increases in DR animals. Birds 
(pigeons, canaries and parakeets, Refs. 12,17) , which are 
especially long-lived homeothermic animals for their body 
size and metabolic rate, also show lower FRL values than 
the much shorter-lived rats or mice. This suggests that a 
low FRL can be a conserved mechanism of life span 
extension both between and within species that can be 
obtained without the need to decrease mitochondrial 
oxygen consumption. That is relevant when it is necessary 
to increase longevity without decreasing the general level 
of animal activity and thus competitiveness in the 
ecological niche. A decrease in FRL can be obtained 
through qualitative changes in the redox mid point 
potential of the complex I ROS generator related to aging. 
This would lead to a decrease in the degree of electronic 
reduction of that generator and thus in complex I mitROSp 
without decreasing electron flow in the ETC and thus 
mitochondrial oxygen consumption. Both a low mitROSp 
and a low FRL at complex I have been reported repeatedly 
at my laboratory in many different investigations in long-
lived animals (11,12,14,17,18,29,47; Table 1). 
Interestingly, a recent extensive proteomic analysis of the 
full ETC in mice showed that partial assembly of the 
"matrix domain-only" of complex I also occurs during ad 
libitum (in addition to the whole complex I protein), but to 
a much lower extent during DR (53). That can help to 
explain both the decrease in mitROSp and the decrease in 
FRL at complex I in DR. Moreover rapamycin, the only 
drug known that consistently increases mouse longevity 
(see section 7), also lowers mitROSp and FRL at complex I 
and decreases the amount of its "matrix domain-only" in 
the mitochondria of mouse liver (53; Table 1). It is that 
matrix domain which seems to contain the subunits 
responsible for the decrease in mitROSp at complex I 
related to species longevity (15,16,18,29) and decreased 
both by DR (44,47) and rapamycin treatment (see below).  
During ad libitum feeding the extra copies of the 
"matrix domain-only" complex I would take electrons 
from NADH but could not pass them to ubiquinone and 
the following complexes of the ETC. This would strongly 
fill up that domain with electrons and would thus strongly 
reduce with electrons the complex I ROS generator/s. This 
would increase mitROSp at this "matrix domain-only" 
complex. The result would be a strong increase in 
mitROSp without any ATP generation, because electrons 
in matrix domain only complex I can not reach the other 
separated complexes. In this way the AL animal would 
have a high FRL because it has both complete complex I 
copies, plus “matrix domain-only” complex I copies that 
increase mitROSp but not oxygen consumption or ETC 
electron flow. In contrast, the DR and the rapamycin-
treated animals have complete fully assembled complex I 
copies and reduced abundance (20-50 % decrease) of 
“matrix domain-only” complex I copies. The DR mice 
would thus exhibit decreases in mitROSp without 
decreases in mitochondrial oxygen consumption (lower 
FRL) with a normal ATP production. Therefore, a 
quantitative decrease in the amount of the "matrix domain-
only" of Complex I can lead to a qualitative change 
(decreased FRL) in DR and rapamycin-treated rodents. 
Lowering of the mid point redox potential of the complex I 
ROS generator would be another (qualitative in this case) 
mechanism than can also contribute to decrease mitROSp 
in long-lived animals (14,17,18,29,47). 
In contrast to mitROSp, which is low both in long-
lived species and in DR rodents, a low DBI occurs in long-
lived species (see the previous section) and in 80 % 
methionine restricted (MetR) rats, but not in 40 % MetR 
(see section 6) or 40 % DR rats. Therefore a low DBI, like 
a low mitROSp, can contribute to decrease aging rate 
during evolution of long-lived animal species. But, in a 
single species, the membrane needs to decrease its 
sensitivity to oxidative damage by lowering fatty acid 
unsaturation only when the level of protein restriction in 
the available food is very strong, whereas the decrease in 
mitROSp is a response already recruited at milder (40 %) 
levels of DR. This makes sense, in principle, since dietary 
protein availability is essential for growing of the 
offspring. At 80 % MetR there is not enough protein for 
adequate growing, and the competitiveness of the offspring 
in the wild would be very low. Therefore it is even more 
important than in 40 % DR to post-pone aging to 
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reproduce only afterwards, when the levels of protein 
availability increase again in the ecological niche. That is 
why, at 80 % protein (methionine) restriction both a low 
mitROSp and a low DBI response are recruited. In relation 
to this, recent comparison among DR diets containing fish 
oil, soybean oil or lard as lipid source, showed that the lard 
containing diet (with less unsaturated fatty acids) was the 
one maximizing the beneficial effects of DR on mitROSp, 
proton leak, ETC, lipid peroxidation, mitochondrial 
structure or mitochondrial apoptotic signaling, likely due 
in part to increases in monounsaturated fatty acid content 
in the tissues (54). This improvement in mitochondrial 
functionality of diets promoting some decrease in tissue 
DBI is consistent again with a healthy and pro-longevity 
effect of membranes containing a low number of fatty acid 
double bonds. 
Finally, since mitROSp is lower in DR than in the ad 
libitum-fed control animals, oxidative damage should also 
be lower in the nearby, or even in contact situated, mtDNA 
of the restricted animals. In agreement with this, it was 
found that the level of 8-oxodG in mtDNA was 
significantly lower in the liver, heart and brain of the long-
term DR rats in which mitochondrial ROS production was 
also diminished (reviewed in 55). Depending on the organ 
studied, such decrease in 8-oxodG occurred only in 
mtDNA, or both in mtDNA and nDNA (Table 1). 
6. PROTEIN AND METHIONINE RESTRICTION 
6.1. Effect on longevity 
It has been generally agreed for a long time that calorie 
intake per se would be exclusively responsible for the 
increase in lifespan induced by DR in rodents. However, 
now many studies question this classical consensus. The 
results of many investigations indicate that part of the life-
extending effects on DR are due to the decreased intake of 
particular components of the diet, such as proteins, and 
more specifically the amino acid methionine (56-60). The 
few available studies do not support the possibility that 
either life-long isocaloric carbohydrate or lipid restriction 
increase rodent life span. Two investigations of 
carbohydrate restriction or supplementation reported 
opposite and minor changes in rat longevity (61, 62), and it 
was found that the longevity of Fisher 344 rats does not 
change after life-long lipid restriction (63). In contrast, the 
large majority of the investigations on the effects of 
isocaloric protein restriction (PR) in rats and mice found 
increases in longevity (Table 1). Ten out of eleven protein 
restriction (PR) investigations in rats or mice (16 out of 18 
different life-long survival experiments) reported increases 
in longevity (58), although the mean magnitude of this 
increase (around 19 %) was lower than that usually found 
in 40 % DR (up to 40 % increase). Thus, PR would be 
responsible for around half of the life-extension effect of 
dietary restriction. 
Among the different dietary amino acids, which is the 
one/s responsible for the increase in longevity induced by 
PR? It is consistently known that isocaloric 80 % 
methionine restriction (MetR) increases longevity in F344 
rats (56) and mice (57-59; Table 1) to a similar extent than 
PR. The mean increase in (maximum) longevity in the 
three available MetR life-long experiments taken together 
was around 18 % increase. This occurred even when MetR 
was started as late as at 12 months of age in C6BF1 mice 
(59). Studies performed in D. melanogaster have also 
shown that casein restriction (64) and methionine 
restriction (65) extend longevity independently of the 
TABLE 1. Summary of changes on free radical related parameters induced by all manipulations known that consistently increase or not 
longevity in mammals laboratory rodents 
  
Experimental manipulation mtROSp    mtVO2  FRL  8oxodG  8oxodG  mtDNAFragments
 Longevity 
    (at CxI)     (at CxI)  in mtDNA in nDNA inside nDNA 
 (MLSP) 
 
DR          !   "    !       !      "   nd       # 
 
 
PR          !   "    !       !      "   nd       # 
 
LR        "   "  "      "      "   nd      "  
 
CHR           "   "  "     "      "   nd      " 
 
MetR              !   "  !     !      "   nd      #  
 
Rapamycin         !   "  !      !(ns)     nd    !      #  
 
   DR= dietary restriction; PR = Protein restriction; LR = lipìd restriction; CHR = Carbohydrate restriction; MetR = methionine restriction; Rapamycin 
(14mg/kg diet). The effects of DR,PR, and MetR on oxidative stress related parameters were obtained at a level of 40% restriction, and also at 80% 
MetR. The effect of MetR on longevity has been studied always restricting methionine by 80% in the diet (56,57,59). The rapamycin effect of 
mitochondrial oxidative stress was studied on B6D2F1 mice (139); the rest of the experiments were performed on Wistar rats. While DR, PR and MetR  
decreased mitROSp and 8-oxodG in mtDNA in all the vital organs studied (liver, heart and brain), rapamycin (at 14mg/Kg diet) did it in liver but not in 
heart of mice; mtDNA fragments inside nDNA were studied in the liver. For other Refs. see text. mtVO2 = mitochondrial oxygen consumption; FRL = % 
free radical leak from CxI of functional mitochondria; nDNA = nuclear DNA; MLSP = maximum life span potential. DR, PR, MetR and rapamycin all 
increase both mean lifespan, and maximum longevity (up to 40% in DR, by 20% in PR and DR, and by 11% with rapamycin) in rats and mice. 
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caloric intake. Moreover, other recent studies link essential 
amino acids, and again especially methionine, with the 
positive effect of DR on longevity in yeast (66) and D. 
melanogaster (67). Interestingly, PR results in profound 
changes in methionine and serine metabolism (including 
lowering cystathionine β-synthase and cystathionine γ-
lyase activities) and increases the oxidation of fatty acids 
in rat liver (68).  
In addition to extending lifespan, 80 % MetR also 
decreases disease-associated markers and the incidence of 
age-related degenerative diseases (69, 70). The beneficial 
effects of this intervention in rodents include decreases in 
serum glucose, insulin, IGF-1, cholesterol, triglycerides 
and leptin. Besides, MetR protects against age-related 
changes in immunity, slows cataract development (57), 
improves colon tight junction barrier function (71) and 
improves metabolic flexibility, increasing respiratory 
uncoupling (72). MetR may be also used in the future to 
inhibit tumor growth, particularly in many cancers that 
exhibit the known phenomenon of “methionine 
dependence”. These include bladder, breast, colon, glioma, 
kidney, melanoma, prostate and other cancers in which 
tumor cells have a much greater reliance on methionine 
than normal cells do (73). They need this amino acid for 
survival and proliferation and their growth seems seriously 
limited or inhibited in the absence of methionine (74, 75). 
MetR (80 %) also decreases total adipose tissue mass 
and lowers visceral fat by 70 % (by more than 40 % after 
correcting for the decrease in body mass) in association 
with an improvement in insulin sensitivity (76). In 
addition, MetR decreases leptin and increases adiponectin 
in rodents in agreement with the decrease in visceral 
adiposity and the size of white adipose tissue depots. 
These beneficial effects seem to be mediated by tissue-
specific responses that favor increased mitochondrial 
function and biogenesis, fatty acid oxidation and total 
energy expenditure possibly mediated by β-adrenergic 
receptor signaling and changes in lipid homeostasis (77). 
Metabolomics and genomic MetR studies found changes 
in the expression of a large number of genes and proteins 
that led the authors to conclude that MetR increases lipid 
metabolism in adipose tissue and muscle whereas it 
decreases lipid synthesis in the liver (78). These changes in 
lipid metabolism seem to be involved in the strong 
decrease in adiposity and increased insulin sensitivity 
observed in isocaloric restriction of dietary methionine. 
Altered levels of sulfur-containing amino acids have 
been also described in MetR: serum levels of methionine, 
cysteine, cystathionine, and taurine decrease in MetR rats, 
whereas homocysteine levels (79) and glutathione (56) 
increase. Interestingly, adding cysteine to the MetR diet 
reverses most of the studied beneficial changes on 
adiposity and insulin resistance (79) and increases the 
transcription of various genes associated with 
inflammation and carcinogenesis (78). Therefore, the 
beneficial changes of the MetR diet have been attributed to 
the decrease of cysteine in serum (80) or liver (78) 
observed in animals subjected to MetR.  
On the other hand, excessive intake of dietary 
methionine is toxic. This toxicity far exceeds that 
produced by any other amino acid (81), leading to damage 
in some vital organs and increases in tissue oxidative stress 
(81, 82) with similar negative effects to those observed in 
rats fed diets with a high protein content. Chronic and 
excessive methionine supplementation increases plasma 
hydroperoxides and LDL-cholesterol (83), induces 
vascular (84) and kidney damage with tubular hypertrophy 
(85), raises iron accumulation and lipid peroxidation, and 
leads to liver dysfunction (86), besides other alterations in 
other organs. In addition, methionine supplementation 
increases methionine and its two more nearly derived 
methionine cycle metabolites, S-adenosylmethyonine and 
S-adenosylhomocysteine in rat liver and kidney (87). 
Some of the harmful effects of methionine 
supplementation have been attributed to methionine-
related metabolites like S-adenosylmethyonine, S-
adenosylhomocysteine, or homocysteine, rather than to 
methionine itself, although in other investigations a direct 
methionine toxic effect has been suggested (80, 84). This 
last case fits well with the observation that direct addition 
of methionine to isolated mitochondria in vitro increases 
their rate of mitROSp in liver and kidney mitochondria 
(87). 
Oxidation of methionine residues in proteins generates 
methionine sulfoxide, depriving them of their function as 
methyl donors and may lead to loss of their biological 
activity (88). This modification can be repaired by 
methionine sulfoxide reductase in a thioredoxin-dependent 
reaction. In this context it is interesting that over-
expression of methionine sulfoxide reductase increases 
lifespan in D. melanogaster (89) and the opposite 
manipulation, knocking out the same enzyme, increases 
protein carbonyls and decreases longevity (90). There is 
evidence that this enzyme plays an important role in 
protection against oxidative, cold, and heat stress and 
seems to be involved in the regulation of aging in D. 
melanogaster (91). Also in agreement with a methionine 
role in aging, it has been reported that long-lived Ames 
dwarf mice have an altered methionine metabolism 
showing a marked increase in the transulfuration pathway 
compared to their wild-type siblings (92). All the above 
results point to methionine as the single dietary factor 
responsible for part of the longevity extension effect of 
dietary restriction. 
6.2. Role of mtROS generation and oxidative damage 
DR decreases oxidative stress in mitochondria. But, 
what is the specific dietary component responsible for the 
decreases in mtROS production and oxidative damage to 
mtDNA during DR? In agreement with their lack of effect 
on longevity (61-63), neither isocaloric 40 % lipid 
restriction (93) nor isocaloric 40 % carbohydrate 
restriction (94) change mitROSp or 8-oxodG in mtDNA 
(Table 1). However, isocaloric 40 % PR during 7 weeks 
decreases mitROSp and oxidative damage to mtDNA in rat 
liver (95) in a strikingly similar way, quantitatively and 
qualitatively to 40 % DR (Table 1). The effect of PR was 
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studied in rat liver without changing the amount eaten per 
day of the other dietary components and it was found, like 
in 40 % DR, that 40 % PR decreases liver mitROSp and 
FRL specifically at complex I, lowers 8-oxodG in mtDNA 
(95, Table 1), and decreases five specific markers of 
protein oxidative, glycoxidative and lipoxidative 
modification as well as the amount of complex I protein in 
rat liver mitochondria and tissue (96). Strikingly, the 
direction of change, the magnitude, mechanisms, and site 
of action exerted by PR on mitROSp and 8-oxodG in 
mtDNA are almost identical to those found in 40 % DR 
(58). Taken together, those studies suggest that proteins 
are the dietary components responsible for most or all the 
decrease in mitROSp and oxidative damage to mtDNA 
that takes place in DR, as well as for part of the increase in 
longevity induced by this dietary intervention. 
 It was logical to suspect that dietary methionine could 
be involved in those PR and DR effects since it was 
already known that MetR, independently of energy 
restriction, increases rat (maximum) longevity (56) while 
such effect had not been described for any of the other 
dietary amino acids. This is why the effects of MetR on 
mitROSp and oxidative stress were studied at my 
laboratory (Table 1). The results showed that isocaloric 
MetR (40 % and 80 %), applied to young rats during 7 
weeks, lowers mitROSp (mainly at complex I), the FRL, 
the complex I content, 8-oxodG in mtDNA (Table 1), and 
specific markers of protein oxidative, glycoxidative and 
lipoxidative modification in rat heart (at 40 % and 80 
%MetR; 97, 98) or liver (at 40 % MetR; 99, 100) 
mitochondria, similarly to what occurs after 7 weeks of 40 
% MetR in rat kidney and brain mitochondria (101, 102). 
In order to obtain these decreases it was enough to restrict 
methionine by 40 % (Table 1). Those decreases in 
mitochondrial ROSp (at complex I) and oxidative stress 
have recently been reproduced in liver mitochondria of 
pigs subjected to MetR (103). 80 % MetR leaded to similar 
decreases in 8-oxodG than in 40 % MetR, while the 
decrease in mitROSp from controls to 40 % MetR rats was 
more pronounced than that occurring from 40 % MetR to 
80 %MetR. 
Most importantly, and consistently with an important 
role of methionine in the DR beneficial effects, when all 
the dietary amino acids -except methionine- were 
restricted (also by 40 %) during 7 weeks, neither the rate 
of mitROSp nor the level of 8-oxodG in mtDNA were 
modified (104). In addition, it was found that 40 %MetR 
also decreases mitROSp, FRL and 8-oxodG in mtDNA 
and reverses aging-related increases in protein 
modification when implemented during only 7 weeks in 24 
months old rats (99). All those results, taken together, 
indicate that the lowered ingestion of methionine during 
MetR (and PR and DR) is responsible for all or most of the 
decreases in mitROSp and oxidative stress observed during 
these three longevity extending manipulations. Such 
lowered methionine ingestion is most likely also 
responsible for all (during PR and MetR) or part (during 
DR) of the life-extension effects observed during these 
dietary manipulations. This extraordinary capacity of a 
single dietary molecule to induce the decrease in mitROSp 
is still present when the animals reach old age. 
Various mechanisms can be responsible for the 
decrease in mtROSp during MetR. A most simple one 
would be based on a decrease in the content of the 
complex I protein in MetR that would directly lead to a 
decreased rate of mitROSp. This has been reported under 
40 % MetR in the majority of tissues studied (Table 1), 
and also during DR and PR, as well as in long-lived birds 
(pigeons, canaries and parakeets) compared to the much 
short-lived mammals (rats and mice) of similar body size 
and weight-specific metabolic rate (105, 106). But, in 
principle, this would not be the full explanation because 
MetR also induces qualitative changes in mitochondria 
because it also decreases FRL. Such decrease could be due 
to a decrease in the mid point potential -and thus the 
degree of electronic reduction- of the complex I ROS 
generator, because the decrease in mitROSp during MetR 
is observed, like in DR, with partial complex I electronic 
reduction (with complex I-linked substrates alone) but not 
with full reduction (complex I-linked substrates plus 
rotenone). The result is that MetR mitochondria (from both 
young and old animals) are more efficient in avoiding 
mtROS generation that those of ad libitum fed rats. MetR 
mitochondria leak less radicals per unit of electron flow in 
the respiratory chain, similarly to what has been found in 
especially long-lived compared to short-lived animal 
species (birds), as well as in DR and PR rats compared to 
ad libitum fed ones (55). These quantitative and qualitative 
changes could be due to: i) direct interaction of 
methionine, or more likely, of a more chemically reactive 
methionine metabolite, with the matrix domain complex I 
polypeptide/s involved in ROS generation; ii) changes in 
cellular signaling molecules and the ensuing modification 
of specific gene expression of mitochondrial proteins; iii) 
decreases in the concentration of mitochondrial complex I 
substrates like pyruvate which would decrease matrix 
NADH and are known to occur at least during DR (see 
section 5). 
 Concerning the possible direct interaction of 
methionine or its metabolites with mitochondria without 
the information passing through the nucleus (mechanism 
"i"), it is known that direct in vitro addition of methionine 
to isolated functional rat mitochondria increases their rates 
of mitROSp (87). Therefore a rather direct and rapid effect 
of methionine on complex I seems to occur. A methionine 
metabolite could be responsible for this effect because in 
methionine, differing from homocysteine or cysteine, the 
potentially reactive sulfur is located inside the molecule 
and is therefore not available for direct covalent chemical 
reaction with protein thiols. Interestingly, the reaction of 
methionine with hydroxyl radicals generates methionine 
radical carbon-, nitrogen- and sulfur-centered radicals as 
intermediates in the formation of the methanetiol product, 
as detected by EPR spin trap techniques and GC-FID and 
GC-MS techniques (107). These radicals or methanetiol 
(CH3SH) itself could react with complex I or some of its 
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subunits leading to increases in mtROS generation. Since 
it is known that GSSG thiolization of isolated complex I 
increases its rate of ROS production (108) a similar 
reaction of methanethiol, or cysteine (which also has a free 
thiol group available for direct reaction) with complex I 
thiol groups could be involved in the decrease in mitROSp 
in MetR. Methionine restriction decreases hepatic 
methionine and cysteine (78) and likely methanetiol levels, 
which can decrease thiolization of complex I subunits and 
then their rates of mitROSp. Alternatively, cysteine could 
also interact with the protein cysteines of some of the FeS 
clusters of the hydrophilic matrix domain of complex I. 
Interestingly, those FeS clusters have been pointed out as 
the ROS generator relevant for aging (15,18,47). Their 
reaction with cysteine would lead to iron release or 
availability for reaction and then to ROS generation. 
Therefore, the lowered cysteine levels in MetR could also 
decrease mitROSp through this kind of mechanism.  
Changes in gene expression can be also involved in the 
MetR effects (mechanism “ii”). MetR studies found 
changes in the expression of a large number of genes and 
proteins involved in lipid metabolism (78). In addition, 
modifications of DNA methylation could be also involved 
(109, 110). Methionine is an essential amino acid with 
many key roles in mammalian metabolism including 
protein synthesis and function, as well as protein and DNA 
methylation (111). Since ageing seems to be associated 
with site-specific changes in DNA methylation (112-116), 
MetR diets could also extend longevity in rodents through 
modulation of DNA methylation patterns, specific changes 
in gene expression, and changes in translation rates, whose 
final effects could include decreases in mtROS generation 
and oxidative damage and increases in autophagy (see 
section 9). In agreement with that, we have recently 
detected that MetR induces a small but statistically 
signiﬁcant decrease in global genomic DNA methylation in 
the heart of young immature rats (98), whereas when this 
manipulation was performed in old rats the decrease in this 
parameter was not statistically signiﬁcant in the liver (99).  
 
Figure 4. Low mitROSp in both long-lived species and in calorie dietary restriction (DR) as a contributor to a low aging rate. This 
low mitROSp decreases oxidative damage to mtDNA (see Figure 2). Oxidation of DNA bases like 8-oxodG are repaired also in 
mitochondria, 8-oxodG being useful as steady-state marker of rate of mtDNA oxidative modification (which is also lower in long-lived 
animals, see Figure 1C and Ref. 20). The final forms of damage responsible for aging (here represented as "somatic DNA mutations" 
should be due to mitROSp also causing DNA strand breaks leading to large mtDNA deletions plus the remaining mtDNA fragments which 
insert into nuclear DNA and accumulate during aging (139; 147-149). The low mitROSp of long-lived animals during DR is due to 
restriction of a single amino acid, methionine, and not to the other amino acids or carbohydrates or fats present in the diet (29,93-
95,97,104). Low fatty acid unsaturation (low double bond index= DBI) also occurs in long-lived animals but not in 40 % DR or 40 % 
MetR (methionine restriction). A decrease in DBI has been observed only at 80 % MetR (which also increases rodent longevity). Since 
the effect of protein restriction or MetR on longevity (ca. 20 %) is around half that of DR (up to 40 %), other mechanisms, in addition to a 
low mitROSp, must be involved in the decrease in aging rate induced by DR. A strong candidate is an increased autophagy (Figures 6 and 
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8, sections 7-9). 
Concerning mechanism “iii”), decreased NADH, it is 
more likely in DR than in MetR, due to the decreased 
ingestion of a large number of metabolites in DR than in 
(isocaloric) MetR. Substrates like pyruvate, malate, and 
succinate, as well as NADH and the NADH/NAD+ ratio 
are indeed decreased in the tissues of rodents subjected to 
DR (45, 46). This will decrease matrix NADH and 
NADH/NAD+ ratio, and therefore the degree of electronic 
reduction of the complex I ROS generator and its rate of 
mitROSp (see section 5). Treatment with a precursor of the 
oxidized form of the coenzyme, NAD+, also rejuvenates 
the skeletal muscle, improves mitochondrial and stem cell 
function in aged mice, and increases their lifespan (117). 
This could be due to a decrease in complex I electronic 
reduction, or to a sirtuin-dependent effect. 
In summary, DR, PR and MetR are nutritional 
interventions that increase longevity in rodents, although 
the magnitude of the longevity extension of MetR and PR 
is around 50 % that of DR. This lower -but significant- life 
extension effect in MetR than in DR would agree with the 
notion that various different environmental signals target 
the cell to modify its aging rate. Restriction of methionine 
intake can be responsible for part of the aging-delaying 
effects of DR by decreasing mitROSp at complex I and 
oxidative damage to mtDNA and macromolecules acting, 
at least in this sense, as a “DR-mimic”. The information 
available strongly indicates that methionine is the single 
dietary substance responsible for the beneficial changes of 
DR on mitochondrial oxidative stress. The remaining 
effects of DR on aging rate could be due to decreases in 
other dietary components, or in the calories themselves, 
acting through different additional signaling mechanisms 
(Figure 4) that could recruit different gene clusters of the 
aging program in the cell nucleus (see section 9), changing 
their gene expression levels with different intensities (see 
section 9). Among those additional longevity-extending 
mechanisms during DR, increased autophagy is emerging 
as most important. In any case, it is interesting that not 
only 80 % MetR, but also 40 % MetR and 40 % PR 
decrease mitochondrial oxidative stress, because PR does 
not involve the stronger behavioral and nutritional stress of 
caloric restriction and therefore seems a much more 
feasible option for wide application to human populations. 
Negative effects such as delays in puberty and decreases in 
growth rate and final body size are shared by (40 %) DR 
and 80 % MetR but do not occur at 40 % MetR. 40 % 
methionine restriction (implemented through PR) could be 
the best kind of dietary restriction for humans because it 
lowers mitROSp and 8-oxodG in mtDNA to a similar 
extent than 80 % MetR, without decreasing at all body and 
organ weight, growth rate, maturation, and likely final 
body size, at variance with what occurs in 80 % MetR and 
40 % DR.  
Humans can obtain health benefits consuming 
“prudent” diets based on the intake of vegetables 
containing proteins rich in essential amino acids but low in 
the sulphur-containing amino acids methionine and 
cysteine (like pulses), or almost totally lacking methionine 
and cysteine (like many fruits and other vegetables), and 
avoiding the presently excessive intake of animal proteins 
and fats typical of western diets. The results already 
available after many years of PR intervention in humans 
seem to be positive for human health and of similar 
character than those found in MetR and DR rats (118). 
These studies also suggest that DR and PR can protect 
from obesity, mortality, and degenerative diseases 
including at least cardiovascular ones, diabetes and cancer, 
and can increase the human healthspan. 
7. RAPAMYCIN, MITOCHONDRIAL OXIDATIVE 
STRESS, AND LONGEVITY 
Although it is well known that DR increases longevity 
in many different animals including mammals, and 
seemingly also in monkeys (41), it is difficult to apply to 
large human populations due to subnutrition risks 
especially in children, very old people, individuals with 
limited cultural knowledge and education, and those with 
some chronic pathologies. Due to this, there is strong 
interest in developing drugs than can increase longevity 
without the need to restrict the human diet (119, 120). The 
USA National Institute of Aging Interventions Testing 
Program (ITP) evaluates the effects of different candidate 
molecules to be candidate antiaging drugs in mice 
(http://www.nia.nih.gov/research/dab/interventions-
testing-program-itp/compounds-testing). These include 
known drugs, antidiabetics, antibiotics and others, like 
aspirin, resveratrol, simvastatin or metformin. While the 
rest of studied compounds have not shown reproducible 
positive effects on longevity (119), rapamycin 
significantly increased both mean lifespan, as well as 
maximum lifespan (at age of 90 % mortality, mean of the 
three sites) by 9 % in males and by 14 % in females in 
heterogeneous strains of mice (121). That experiment was 
reproduced under the NIA ITP at three different sites. 
Posterior studies have confirmed those results and have 
shown that dietary rapamycin extends lifespan when 
initiated in young (119) or middle aged mice (122), or in 
mixed age mice (123). Therefore, rapamycin is widely 
recognized as the first drug known that consistently 
increases longevity in mammals. Rapamycin also increase 
longevity in yeast (124), C. elegans (125) and Drosophila 
(126) through inhibition of the TOR protein complex, 
equivalent to mTOR (mammalian target of rapamycin). 
This indicates that this longevity pathway is highly 
conserved in evolution. The mTOR complex also shows 
signs of rapid evolution in amniotes and signs of positive 
selection (127). 
Although it is clear that rapamycin increases 
mammalian longevity, the final effector mechanisms 
involved were unknown, although decreases in 
mitochondrial damage, increases in autophagy, or 
modifications in cell growth/proliferation could be 
implicated. Rapamycin also inhibits the mTOR signaling 
pathway in mammals (128). Interestingly, the longevity 
extending nutritional intervention DR also decreases 
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mTOR function (129). This indicates the existence of 
overlapping mechanisms of action for rapamycin and DR. 
Rapamycin treatment decreases body weight and food 
intake in mice (130) but the increase in longevity induced 
by the drug is independent of the decrease in food intake 
per se. However, since the longevity extension effect of 
DR (up to 40 %) is much larger than that of rapamycin 
(around 11 %), rapamycin controls only part of the final 
aging effector mechanisms increasing longevity during DR 
or affects them with smaller intensity than DR, or does not 
affect similarly all mammalian organs. Most likely DR 
targets also other cytosolic pre-nuclear longevity signaling 
molecules (see section 9) different from mTOR that are 
not targeted by rapamycin. Alternatively, there is evidence 
that DR directly modifies some of the most likely effectors 
of aging like mitROSp, by-passing the nuclear aging 
program (section 9), e.g, by decreasing mitochondrial 
matrix NADH due to lower concentrations of complex I-
linked substrates like pyruvate (see sections 5 and 6). 
In addition to increasing longevity, there is a general 
consensus that rapamycin attenuates age-associated 
declines in some measures of cardiac, immune, muscular, 
and cognitive function (122, 131). The increase in 
longevity induced by rapamycin was initially unexpected, 
because rapamycin was used, together with other drugs, in 
post-transplant therapy (132). Strikingly, increases (instead 
of decreases) in various immune activities have been also 
observed at low rapamycin doses (129, 133). It is now 
known that mTOR inhibition in mammals has positive 
functional effects in the majority of the physiological 
systems (129, 131), and protection from degenerative 
diseases, solid tumors, cardiovascular metabolic diseases 
and obesity have been observed even in humans. 
Rapamycin also prevented from degenerative brain 
changes in an Alzheimer disease mouse model and 
improved anxiety and depression in normal mice (134). 
Although some detrimental effects of the drug have been 
described, the positive effects are much more diverse and 
extensive. In any case the global effect of rapamycin is 
positive since both mean and maximum longevity are 
increased.  
DR increases longevity and lowers mitROSp, FRL, and 
oxidative stress (29), as well as mTOR function (59). And 
intermittent rapamycin administration, like intermittent 
DR, also extends lifespan of female mice (135). Decreased 
mTOR downstream activity could constitute one of the 
various signaling mechanisms through which DR 
decreases aging rate (129, 136, 137). In agreement with 
this, knocking out the gene coding the ribosome protein 
kinase S6K (a main target of mTOR signaling) slowed 
aging of bone, immune, and motor functions, and led to a 
larger than normal longevity (138). In many cases the 
nuclear gene response to these signals (see section 9) 
slows the aging rate. Among them, the decrease in 
mitROSp produced by both DR and rapamycin can be 
important. In agreement with this concept, rapamycin 
dietary treatment, at the same dose that increased longevity 
(121), decreased hepatic mitROSp (Figure 5A) and FRL at 
complex I both in mice subjected to a diet that induced 
fatty liver (53) as well as in middle aged mice receiving 
standard (LabDiet 5LG6 w) diets (139; Table 1).  
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Figure 5. Rapamycin fully reverses the age-related increases in mitROSp and mtDNA fragments inside nuclear DNA. Rapamycin 
dietary treatment, at the same dose that increases mouse longevity (14 mg/Kg diet, Ref. 121), totally abolished the A) age-related increase 
in mitROSp, and B) the accumulation of mtDNA fragments inside nDNA in the liver of middle-aged mice (16 months of age). In part B 
the pictures show single representative hepatocyte nuclei corresponding to: a) YOUNG; b) MID; c) MIDRAPA; red signals come from 
mtDNA; green signals from minor satellite mouse centromeric sequence (MiSat) were used as controls; white bar is equal to 2µm. MID = 
Middle aged mice. MIDRAPA = middle aged mice treated with rapamycin during 7 weeks. a: significantly different from Young group; b: 
significantly different from Middle group; * P<0.05, *** P<0.001. The qualitative and quantitative similarity of the changes induced by 
rapamycin in both parameters suggest a cause-effect relationship between them. Modified from ref. 139. 
Moreover, this drug completely reversed age-related 
increases in mitROSp (Figure 5A), and the age-related 
increase in the insertion of mtDNA fragments inside 
nDNA, in the liver of middle aged mice (139; Figure 5B; 
see also section 8). In the same investigation, it also 
completely reversed age-related decreases in the 
autophagocytosis marker ATG13 (Figure 6A), and 
partially reversed the accumulation of the best tissue 
marker of aging, lipofuscin, in the liver (Figure 6B). 
Rapamycin also increases mouse longevity when the 
treatment is started at middle age, with an effect similar to 
that observed starting at 9 months (119, 121), agreeing 
again with the decreases observed in mitROSp also in 
middle aged mice (139). All those results, taken together, 
are most remarkable since there is currently strong interest 
in finding drugs with positive effects on longevity in 
middle aged humans. 
In summary, it is most interesting that all the (four) 
experimental manipulations which consistently and 
reproducibly increase both mean and maximum longevity 
in mammals, DR, PR, MetR and rapamycin, decrease 
mitROSp and FRL at complex I and mtDNA damage 
(Table 1). This strongly supports the antioxidant-
independent version of MFRTA exposed in this review that 
focuses on: i) the rates of ROS production (initiation) at 
mitochondria; and ii) cellular components highly resistant 
to (oxidative) modifications like less unsaturated 
membrane fatty acids (low DBI). These two traits of the 
updated MFRTA could be accompanied by a third related 
factor in long-lived animals, iii) increased autophagy (see 
section 9). 
   
 
Figure 6. Rapamycin totally reverses the age-related decrease in autophagy and partially reverses the increase in lipofuscin 
accumulation. Rapamycin dietary treatment of middle aged mice (16 months of age), at the same dose that increases mouse longevity (14 
mg/Kg diet, Ref. 121) totally abolished A) the age-related decrease in the autophagocytosis marker protein ATG13, and B) partially 
reversed the age-related accumulation of lipofuscin (B) in the liver of middle-aged mice (16 months of age). In part B the pictures show 
single representative hepatocytes corresponding to: a) YOUNG; b) MID; c) MIDRAPA; bright red signals come from lipofuscin; the 
nucleus is seen in blue colour; white bar is equal to 10µm. MID = Middle aged mice. MIDRAPA = middle aged mice treated with 
rapamycin during 7 weeks. a: significantly different from Young group; b: significantly different from Middle group; * P<0.05; *** P<0.001. 
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The inverse nature of the changes induced by rapamycin in both parameters suggest a cause-effect relationship between the increase in 
autophagy and the partial reversal of lipofuscin accumulation. Modified from ref. 139. 
8. mtDNA FRAGMENTS INSIDE NUCLEAR DNA 
AND AGING  
A further complication is the possibility that 
mitochondrial ROS-derived damage affects aging genes 
back in the nucleus through the insertion of mtDNA 
fragments inside nDNA (Figures 5B and 7).  
Oxidative damage to mtDNA bases, like 8-oxodG, is 
also repaired in the mitochondria. But mitROS, in addition 
to DNA base and sugar oxidative modifications, have the 
capacity to produce double strand breaks in DNA in 
general, and with more reason in the very nearby situated 
mtDNA. Fragmentation of mtDNA through double strand 
breaks by the nearby generated mitROS can be one cause 
of the well known accumulation of mtDNA mutations, 
including large mtDNA deletions, with age (140). 
Recently, it has been proposed that mtDNA mutations can 
also be due to errors during DNA replication and repair, 
rather than to mitROSp. However, while those random 
errors can contribute to accumulated damage during the 
lifespan of a single individual, they can not be responsible 
for the strongly different longevity of the different species 
nor for the change in longevity induced by the different 
kinds o DRs, since these longevities are genetically, 
instead of randomly, controlled. In other words, there is no 
plausible mechanisms that would lead rats to commit 30 
fold more errors than humans during mtDNA replication 
or repair. Replication and repair as source of mtDNA 
mutations suffers the same limitation that many other 
wrong proposals based on random processes (e.g. wear and 
tear theories of aging). Instead, the longevity of a species, 
or fine tuning of longevity to a new level in DR, is 
determined by the genotype. Then, it must necessarily be 
due to the existence of genetically programmed processes 
residing in the cell nucleus which can respond to 
environmental nutrient availability (during DRs) with 
appropriate changes in longevity (see section 9). 
 
 
Figure 7 mtROSp and mtDNA fragments inside nuclear DNA. mtROS produced at Cx I generators (stars) cause damage in the mtDNA 
situated nearby or even in contact with the complex I site of ROS production. This causes, in addition to oxidized bases, double strand 
breaks leading to large deletions and, most importantly, also mtDNA fragments. These exit the mitochondria and insert into nuclear DNA at the 
centromeres during aging in yeast, rats and mice, and contribute to aging. This is reminiscent of what happened during evolution after the 
symbiogenesis of the eukaryotic cell from α-proteobacteria and Archea around 2.000 million years ago. Rapamycin treatment decreases such 
mtDNA fragment accumulation in the liver of middle aged mice (Figure 5B; Refs. 139,143-149). 
The occurrence of large mtDNA deletions, which 
increase with age in mammalian tissues, has been 
proposed as one final detrimental effect causing aging. 
Since mtDNA is highly compacted, without introns, the 
large deletions detected in old tissues would lead to the 
lack of many genes coding for electron transport chain or 
mitochondrial ribosome subunits in a single mtDNA circle 
molecule. However it is now clear that, with the exception 
of a few tissues, the level of these deletions does not reach 
the threshold needed, in homoplasmia, to be of negative 
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functional consequences in most tissues of old animals. 
The high level of heteroplasmia of mtDNA, due to the 
presence of thousands of mitochondria per cell, and 
various mtDNA copies per mitochondrion, strongly 
protects against direct functional effects of mtDNA 
mutations. Many copies of mtDNA are present in each 
cell. Only if a large majority of these mtDNA copies are 
mutated, mitochondrial ATP production would be 
compromised. Cells essentially homoplasmic for deleted 
mtDNA are abundant (between 43 and 60 %) in a few 
areas like substantia nigra in humans (141, 142), but in the 
brain in general and in other vital tissues of old individuals 
their percentage is too low (0.5-2 %) to cause damage 
during aging. 
However, double strand breaks in mtDNA not only can 
generate mtDNA deletions. At the same time than they 
generate deletions, they produce mtDNA fragments, the 
segments of deleted mtDNA. In agreement with earlier 
proposals (143,144) those fragments can escape from 
mitochondria (145, 146) and are also present inside the 
nucleus (Figures 5B and 7). It was proposed that this could 
randomly change nuclear gene information and thereby 
contribute to cause cancer and aging (143). It has been 
simultaneously demonstrated that these mtDNA fragments 
accumulate inside nDNA with age both in yeast (147) and 
in rat liver and brain (148), and that such accumulation 
causes damage and contributes to aging in yeast (149). 
Mouse liver also accumulates mtDNA fragments inserted 
inside nDNA with age (139). And the dietary treatment 
with rapamycin, in addition to decreasing mitROSp, 
totally reversed mtDNA fragments accumulation in nDNA 
(139; Figure 5A,B) and decreased lipofuscin (materials 
non-autophagocytosed; Figure 6B) in middle-aged mice. 
This last change can be due to a decrease in the presence 
of damaged mitochondria, and/or to the increase in 
autophagy induced by the drug (139, Figure 6A). The 
changes observed for mitROSp and for mtDNA fragments 
inserted in nDNA are strikingly similar since full(100 %) 
reversion of age related increases occurred in both cases 
(Figure 5A,B). This could be due to a cause-effect 
relationship between these two parameters, since ROS 
have strong capacity to produce double strand breaks and 
then DNA fragmentation. The increase in autophagy and 
the decrease in lipofuscin could also represent a cause-
effect relationship (Figure 6A,B) although in the case of 
lipofuscin reversion to young levels was only partial.  
In summary, part of the increase in longevity of 
rapamycin treated mice can be due to: (i) a decrease in 
mitROSp; (ii) a decrease in the insertion of mtDNA 
fragments inside nDNA; and (iii) an increase in 
autophagy. Interestingly, in a parallel experiment we did 
not detect significant changes in mitROSp in the heart 
after the rapamycin treatment. Therefore, the reason why 
rapamycin increases life span to a much lower extent (11 
% increase in maximum lifespan) than DR (up to 40 % 
increase) can be due to the impact of DR on more 
longevity signaling pathways than those involving mTOR 
(Figure 8). But it can also be due to the possibility that 
rapamycin decreases mitROSp, or increases autophagy, in 
some but not in all organs at least at the dose used of 14 
mg of rapamycin/Kg of diet (121, 139). 
The decrease in mitROSp and FRL induced by 
rapamycin treatment in mouse liver occurred together with 
decreases in the amount of complex I, which contains the 
ROS generator relevant for aging (see previous sections). 
That was associated with an increase (instead of decrease) 
in mitochondrial biogenesis (139; PGC1α). A possible 
explanation of this apparently paradoxical result is that 
rapamycin could selectively induce mitochondrial 
biogenesis from the more youthful pool of liver 
mitochondria. These are expected to show lowered FRL 
than the more damaged ones. That selection could be 
another reason why rapamycin decreased mitROSp. It has 
been observed that rapamycin increases autophagy and 
mitochondrial biogenesis in mouse heart suggesting that 
damaged mitochondria are replaced by newly synthesized 
ones to rejuvenate mitochondrial homeostasis. Likely 
related to this possibility, it has been observed that DR 
(which also inhibits mTOR) and rapamycin both lower 
mitROSp and FRL and decrease the amount of the "matrix 
domain-only" of complex I in the mitochondria of mouse 
liver (53). That matrix domain contains the mitROS 
generator responsible for the decrease in mitROSp during 
DR (15-18,47,53) and during rapamycin treatment (139). 
The mtDNA fragments exit from the mitochondria 
towards the nucleus during the lifetime of the individual 
and they insert into nDNA. They are visualized heavily 
concentrated at the centromeres (Figure 5B, a-c 139). 
Thus, the centromeres seem to be the “entry doors” for the 
access of mtDNA fragments into chromosomes, perhaps to 
be distributed afterwards to other specific chromosome 
locations at regulatory regions of the master genes 
controlling the "Gene Clusters of Aging" (constituting the 
pro-aging program) likely lying in the cell nucleus (see 
section 9). The final result would be to promote aging and 
degenerative diseases including cancer. If that 
phenomenon finally were a regulated one, the initial 
proposal (143) would only be wrong concerning the 
suggested randomness of the process. Random insertion of 
mtDNA fragments inside nDNA, even if it were restricted 
to the structural genes (around 1 % of total nDNA) could 
cause cancer (e.g., inserting in, and randomly inactivating 
tumour suppressor genes) but not aging, because species 
longevity is a tightly regulated species-specific property. 
Further studies are needed to ascertain the random or 
regulated character of mtDNA fragments insertion into 
nDNA starting at the centromeres. 
 Migration of mtDNA fragments from mitochondria to 
nucleus is strongly reminiscent of what happened during 
millions of years of evolution after the symbiogenesis 
event that created the Eukaryotic cell around 2.000 million 
years ago. During such evolution most genes of the 
initially free living Rickettsia-like α-proteobacteria were 
transferred to what is now the nuclear genome of the 
eukaryotic cell. This would constitute a further example of 
the old observation that in various cases “ontogeny 
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recapitulates phylogeny” (e.g. presence of gills or tail in 
human embryo or foetus), in this case applied to 
programmed aging as a continuation of development. 
The lack of increase to phenotypic threshold (minimum 
of around 60 %-80 % deleted) of mtDNA deletions due to 
the very high copy number of mtDNA in heteroplasmia 
per cell was a strong problem for the validity of MFRTA, 
similarly to the main origin of mtDNA point mutations 
from replication/repair instead of from mitROSp as 
deduced from the relative frequency of base transversions 
vs. transitions. However, now there is evidence that 
mtDNA fragments accumulate inside nDNA with age in 
yeast and mammals, and that this promotes aging (147). 
Furthermore, the longevity increasing drug rapamycin 
reverses such age-related accumulation in mouse liver 
strongly paralleling what happens for complex I mitROSp 
(Figure 5A,B; Ref.139). All that means that MFRTA can 
not be considered “dead” any more except by those not 
aware of the recent breakthrough discoveries of mtDNA 
transfer from mitochondria to the nucleus during the 
lifetime of the individual. On the contrary MFRTA, like 
the bird phoenix, emerges again well alive and all pristine 
from its ashes. Perhaps the failure to detect mtDNA 
mutations relevant for aging has been due to looking at the 
wrong place. The ROS related to aging should be looked at 
mitochondria. However, what could be more important for 
aging would not be the (remaining) deleted mtDNA, but 
what is lacking at mtDNA after the deletion: the mtDNA 
fragments. The consequences likely relevant for aging, the 
mtDNA fragments, have been found inserted into nDNA 
inside the nucleus. Therefore, we should look both at the 
mitochondria and to the nucleus to understand aging, 
as much as we should look at the mitochondria and at the 
nucleus to understand the creation and further evolution of 
the eukaryotic cell. 
9. THE CELLULAR AGING REGULATION 
SYSTEM (CARS)  
9.1. Signaling, the nuclear Aging Program, and aging 
Effectors 
The integrated Cellular Aging Regulation System, for 
convenience called CARS here for the first time, is 
composed of three main parts (Figure 8):  
A) Cytoplasmic Pre-nuclear Signaling (mostly 
signaling proteins)  
B) The nuclear genetic Pro Aging Program (PAP) 
including the Gene Clusters of Aging (153); and  
C) Post-nuclear Effectors (executors) of Aging.  
This CARS occurs both in post-mitotic and in mitotic 
tissue cells. Mitotic cells could harbour, in addition, other 
additional hypothetical aging effectors specific for such 
kinds of tissues, like telomere shortening or perhaps 
apoptosis, but these are not expected to be relevant in cells 
that do not divide. Especially, if the cell does not divide, 
the telomeres would not shorten. And the most important 
tissues for mammalian aging are those mainly composed 
of post-mitotic cells, skeletal muscle, heart and brain.  
 
Figure 8. Cell Aging Regulation System (CARS). The working model of the CARS (including the Pro Aging Program-PAP lying inside the 
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nucleus) broadly depicts known mechanisms of control of longevity at cell level. Different kinds of dietary restrictions (DR, PR, MetR) and 
rapamycin (signals coming from the environment) alter humoral, endocrine, and finally cytosolic pre-PAP signaling proteins like mTOR, 
AMPK, and many others (part A, left of figure). In many cases this modifies the expression (through transcription factors like FOXOs, TEFB 
and others) of nuclear genes likely organized as Gene Clusters of Aging (153) of the PAP (part B center). PAP output (solid arrows leaving the 
nucleus on the right of the figure), in turn, modifies the activity of at least three Aging Effectors (shown in italics, Part C, right): a) Mitochondria 
(including mitROSp), b) fatty acid double bond index (DBI), and c) and likely Autophagy. The integrated responses of the aging effectors to the 
DRs and rapamycin, or to knocking out GH or IGF-1/insulin-like signaling genes increases longevity. Across species the same (plus additional) 
genes forming the PAP are constitutively active at different levels in species with different longevities. In some cases the signals can reach the 
mitochondria directly by-passing the nuclear PAP, as it is the case for MetR possibly lowering cysteine thiol groups at complex I (Ref. 159). 
The action of other possible effectors of aging like telomere shortening or apoptosis is likely limited to mitotic tissue cells and evidences for 
their validity are still lacking. mtDNA deletions, and mtDNA fragments inserted in the nucleus increase with age (139,147-49) and can 
contribute to aging (139,149). Mitochondrial ROSp (and updated MFRTA) are not alternative to the humoral (e.g. insulin-IGF-1 like) or 
cytosolic proteins (e.g. mTOR or S6K) part of CARS and signaling to PAP. Instead, the three main kinds of cellular processes (A, B and C) 
work together integrated into a single CARS to control longevity in each species and to finely adjust changes in longevity in response to DRs or 
pro-longevity drugs like rapamycin. During 40 % DR lowered mitROSp and increased autophagy execute the PAP response. At 80 % (but not 
40 %) MetR, decreasing the DBI is also a recruited response. These three aging effectors can be involved in the change in longevity between 
species. Epigenetics can be also involved in changing the PAP gene expression level. DBI (double bond index) indicates the number of 
double bonds of membrane fatty acids (DBI). ECF = extracellular fluids; MFRTA= mitochondrial free radical theory of aging. 
Intensive aging research during the present century, 
including studies with gene knockout and transgenic 
animals, has clarified a series of important facts 
concerning the CARS:  
a) Inactivation of many single genes leads to an 
increase in mouse longevity (up to, ca., 40 %). Most 
importantly, those genes are highly conserved in evolution 
which agrees with the concept that aging is an adaptation 
that increases biological fitness at group or higher level. 
Thus, aging constitutes a good example of an adaptation 
covered under the umbrella of the modern concept of 
Multilevel Selection. Many of those genes are the 
homologous in organisms so different as yeast, nematodes 
like C. elegans, insects like Droshophila, and many 
vertebrates including mammals and humans. Therefore, 
aging is a very old adaptation of most multicellular and 
even at least the unicellular eukaryotic life. 
b) Although DR (and MetR) can control aging in part 
by directly modifying the aging effectors, they also bring 
about changes in expression of a large number of nuclear 
genes (78,150,151). The modified expression of those 
genes, in turn, modifies the activity of the three known 
aging effectors too. 
c) The different kinds of DRs increase mouse longevity 
by modifying the expression levels of hundreds of genes, 
as shown by many microarray-based studies. Those 
changes are species- and tissue-specific. This, together 
with the increase in longevity after inactivation of single 
genes codifying for pre-nuclear hormones, their receptors, 
cytoplasmic signaling proteins or transcription factors (part 
A of the CARS), constitutes robust evidence that a Pro-
Aging Program (PAP) exists in the cell nucleus. 
d) DR and MetR signal the abundance of food or 
proteins available for feeding in the external world to the 
cell inside the body using humoral factors like insulin, 
GH/IGF-1, or blood amino acids like methionine. These in 
turn modify the activity of many cytoplasmic signaling 
proteins like mTOR, S6K, AMPK, AKT, PI3K, FGF21, 
ULK1, NFkB, HIF and many others. Many of those 
signals enter the nucleus, where, through the action of 
transcription factors like FOXOs or TFEB (152), modify 
the expression of PAP genes involved in the control of 
longevity. These have been proposed to be organized in 
different but interrelated Gene Clusters of Aging, 
analogously to the Hox genes located in four clusters and 
involved in the control of development from embryo to 
adult (153). 
e) Most long-lived mouse mutants live up to 40 % 
longer than the wild type animals. This, most interestingly, 
coincides with the amount of longevity extension elicited 
by DR (also up to 40 %). Many of those known genes 
mainly codify for proteins involved in GH/ or insulin/IGF-
1-like Pre-nuclear Signaling, or cytoplasmic pre-PAP 
cytosolic signaling proteins, or nuclear transcription 
factors like FOXOs or TFEB.  
f) The cytosolic signaling proteins work in many cases 
by modification of nuclear PAP activity. The induced 
changes in gene expression modify the levels of specific 
proteins corresponding to PAP output. The final result is 
the variation in activity level of the systems finally 
controlling the rate of aging, the cellular Post-nuclear 
Aging Effectors. Three of them have been already 
identified:  
(i) The Mitochondria, and their rate of mitROSp at 
complex I 
(ii) The degree of Unsaturation of Cell Membrane 
Fatty Acids (DBI); and  
(iii) Likely, the Macro-Autophagocytosis (Autophagy) 
system.  
These three main effectors are operative in aerobic 
vital tissues, both mitotic and post-mitotic. The action of 
other possible effectors like telomere shortening or 
apoptosis would be restricted to mitotic cells, of smaller 
relevance for aging. Therefore increased longevity, both 
during DRs and between different animal species, is 
obtained through decreased mitROSp at complex I, and 
increased autophagy. A decrease in cell membrane DBI is 
involved also in increasing longevity across species.  
The first two aging effectors (mitROSp and DBI) were 
identified in the 1990´s. With these two the key to long life 
is to decrease the rate of generation of (oxidative) damage 
at mitochondria; and to have cellular membranes, 
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including those of mitochondria, composed of fatty acid 
constituents more resistant (with less double bonds) to 
ROS induced damage. Now autophagy is emerging as a 
third possible aging effector. Macro-autophagy (154) can 
eliminate heavily cross-linked, oxidized, and aggregated 
mixtures of peroxidized lipids and proteins (155) and even 
sometimes whole heavily damaged mitochondria (156). 
Thus animals like us seem to age slowly at least because 
they "purposely" (in evolutionary sense) produce less toxic 
substances (ROS) per unit time, their membrane fatty acids 
are more resistant to them, and most of the still remaining 
molecular damage is eliminated by the macro-
autophagocytosis machinery. This shows the strong 
interrelationship between the three aging effectors. The 
materials that can not be digested and eliminated by 
autophagy accumulate in the cytosol as lipofuscin 
granules, the best known marker of aging at tissue level. 
Many different mutant mice with single autophagy 
genes knocked out have a decreased life span (reviewed in 
154). However, we still lack rigorous evidence that over-
expression of macro-autophagy genes increases longevity. 
The same problem affects DBI except for successful 
knocking out of desaturase/elongase genes that increased 
longevity in C. elegans nematodes. It is known, hoever, 
that mitROSp at complex I, consistently decreases in all 
the four known experimental manipulations that increase 
mammalian longevity: DR, PR, MetR, and rapamycin 
feeding. Some positive evidence suggesting that 
increasing autophagy increases longevity has been 
published, although it was limited to a short-lived mice 
strain in which overexpression of the essential 
autophagosomal protein ATG5 increased maximum 
lifespan from only 781 to 900 days (157). In contrast, in 
the first three experiments taken together in which 
rapamycin increased longevity the control mice of both 
sexes reached 1,086 days and the rapamycin treated ones 
reached 1,212 days of age at 90 % mortality (121), a 
capacity surpassed by MetR and DR.  
The husbandry conditions and the strain used clearly 
affect the longevity attained by the animals in aging 
experiments. Further aging experiments using longer lived 
control mice, approaching 1,000-1,200 days at least, are 
needed to identify other drugs that could increase 
longevity. It is necessary to use long-lived instead of short-
lived strains as controls, and to implement husbandry 
conditions that maximize longevity and produce more 
rectangular and smooth survival curves.  
Another key requisite for acceptation of any theory of 
aging is that it must be able to explain why different 
animals age at so different rates. It is still unknown 
whether autophagy is higher or not in tissues of long-lived 
animals compared to those of short-lived ones. However, 
telomere length is higher in mice than in men, the opposite 
of what is expected if telomere shortening were another 
causal factor involved in aging. Consistent and 
reproducible evidence concerning these aspects is urgently 
needed before definitively considering macro-autophagy a 
third aging effector. In addition, when those comparative 
studies are performed, care must be taken not to correct 
the real values by body size because this will erase most of 
the real causes of aging responsible for the correlations 
between the studied hypothetical mechanism of aging and 
longevity. If the authors of a study still doubt whether to 
correct or not correct for body size, the best option would 
be to show in the publications the correlations with 
longevity for both the corrected and the non corrected 
values. That is most important. Otherwise, the high 
potential of comparative gerontology to facilitate the cheap 
and fast possible identification or elimination of 
hypothetical causes of aging will be almost fully erased, 
which will be a too great loss for gerontology.  
Although correlation does not imply causality, the 
central parameters of any valid theory of aging must 
correlate with the longevity of different species in the right 
sense. Thus, mitROSp is low in tissues of long-lived 
mammals and birds, which fully fits with the modern 
version of MFRTA. On the contrary, antioxidant enzymes 
also correlate with longevity but in the wrong sense: they 
are up to more than one order of magnitude lower (instead 
of higher) in long-lived than in short-lived mammals or 
vertebrates (7). The same is true for the repair of DNA 
damage of endogenous origin (reviewed in 29, section 
3E1). Therefore, both defence (antioxidants) and DNA 
repair are discarded as causes of aging. High 
"maintenance" of the animal (leading to high longevity) is 
not due to defence plus repair contrarily to what the three 
mainstream evolutionary theories of aging (mutation 
accumulation, antagonist pleiotropy, and disposable soma 
theory) wrongly predicted. On the contrary high 
maintenance is due to a low rate of generation of 
endogenous damage (low mitROSp and low DBI) and, 
likely, also to a high rate of elimination of damaged 
components (high autophagy). MitROSp and autophagy 
are strongly complementary mechanisms, helped also by a 
third factor: high resistance of tissue cellular membranes 
to lipid peroxidation obtained through a low DBI and PI. 
In short, longevity is obtained through a low rate of 
production of "damage" (mitROS,), a high rate of 
cleaning their consequences (high autophagy), and a 
high constitutive resistance to oxidative modification 
(e.g., low DBI). The identification of the rate of mitROSp 
with the concept of "rate of generation of endogenous 
damage" comes from the fact that, after more than one 
century of intensive gerontological research, ROS continue 
to be the only know highly damaging substances 
endogenously produced by the healthy animal organism 
throughout their lives that have the capacity to break 
covalent bonds. If any other different family of substances 
having that property is discovered in the future, it could be 
tested to be added or not to the list of aging effectors. 
Meanwhile mitROS continue to be the only toxic highly 
damaging substances that the body "purposely" produces 
to cause and increase its aging rate. 
The Pre-nuclear Signals, the PAP, and the Aging 
Effectors, are integrated working together to constitute the 
CARS. Therefore, it is illogic to consider MFRTA 
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incorrect while believing at the same time that proteins 
like mTOR, AMPK or S6K, et cetera, control longevity. 
Looking at Figure 8 it is evident that the three parts of the 
CARS work together in a highly integrated manner to 
determine species longevity.  
On the other hand, it is logical to suspect that the same 
gene clusters of aging central to the PAP and reacting to 
the DRs or rapamycin, plus others additional ones, are also 
involved in the control of longevity between different 
species. It is already known that different genes can 
change their expression at different tissues in response to 
the different kinds of dietary restrictions (DR, PR, MetR, 
or IF-intermittent feeding) or pro-longevity drugs. These 
responses include both quantitative and qualitative 
changes concerning the genes involved in each case as 
well as their levels of gene expression. The same is 
expected between species with much bigger differences in 
longevity than in the DRs. Between species, the same 
genes involved in response to the DRs would be involved, 
plus additional inter-species genes. The degree of 
expression of the longevity genes involved is expected to 
vary more intensely in different species than in the DRs. 
Since the number of genes involved in the response to DR 
is already large (up to 1.000) in relation to the total 
structural genes (around 20.000 genes), it would be a 
prohibited luxury for evolution to use totally different 
genes to control aging rate in the case of the different 
species than in the DRs. Instead, the same genes would be 
used, plus additional inter-specific ones. One well known 
example is the case of oxidative stress. While both 
mitROSp and cell membrane DBI (global fatty acid 
unsaturation) varies between species, in the case of (40 %) 
DR and (40 %) MetR mitROSp at complex I is decreased 
while the DBI does not change (see section 5). However, 
at 80 % MetR, the DBI is also lowered (97). Thus, the 
implication of a given effector in a response depends on 
whether: a) the longevity difference occurs at the 
individual or at the species level; and b) the intensity of the 
signal reaching the PAP. In addition, there can be also 
inter-individual differences involved. Transcriptions 
factors like FOXO1 reacting to DR show polymorphisms 
in relation to differences in longevity in human 
populations (158). 
Although a large part of the change in aging rate is 
controlled by the flow of information through the PAP in 
the nucleus, at least in the case of mitochondria part of the 
control can directly flow from the dietary substances and 
derived substrates to modify mitROSp bypassing the PAP. 
This occurs in DR, that decreases metabolites like 
pyruvate and others, which in turn lower matrix NADH 
and then mitROSp at complex I (Figure 8 top). Or the case 
of MetR, in which direct control of mitROSp by post-
translational modification of complex I could occur. 
Reaction with complex I thiol cysteine groups could 
decrease the degree of electronic reduction of the complex 
I ROS generator - like the lowered NADH in DR- and then 
its rate of mitROSp (159). On the other hand, components 
of CARS are interrelated in more complex ways than 
delineated in Figure 8. Thus, the mitochondrial uncoupler 
2,4-dinitrophenol lowers mitROSp, which is expected 
since it accelerates electron flow at ETC, like during the 
state 4 (without ADP) to state 3 (with ADP) energy 
transition. However, it also lowers mTOR activity and 
insulin-PI3K-MAPK signaling, and increases autophagy 
(160).  
Another example is the recent description that lowering 
mitROSp decreases the amount of damaged mitochondria 
and the cellular level of lipofuscin (161), again relating 
two main cellular effectors of longevity of post-mitotic 
cells, mitochondria and autophagy. Mitochondria have 
been repeatedly observed half digested inside secondary 
lysosomes under the electron microscope, these vesicles 
contributing afterwards to form lipofuscin granules 
Strikingly, many genes controlling autophagy are the same 
involved in the increase in longevity induced by lowering 
mitochondrial respiration (154). 
9.2. Intermittent food restriction (IF): is the Aging 
Program functioning gradual or not? 
It would be most interesting to know whether the PAP 
works in a graded form in response to DR or like an ON-
OFF switch. The last possibility is supported by the fact 
that DR can also be performed by intermittent fasting (IF) 
instead of decreasing the calories or methionine eaten per 
day by the DR animals. It is known that IF rodents 
increase longevity even in strains that gorge the days that 
they receive food. In this last case, even though the total 
number of calories eaten is roughly the same in the IF 
animals and the controls, longevity still increases in IF. 
This apparently paradoxical result would be explained if 
the PAP genes react to DR (Figure 8), at least to a certain 
extent, in an ON-OFF fashion, instead of responding in 
strict proportion to the amount of calories eaten. If this 
were the case, when the animal eats a certain amount of 
food and a threshold of calories is reached, the PAP would 
increase its activity output (increase its aging effectors) 
from a low (called “OFF” for simplicity) to a higher 
(“ON”) level, irrespective of the amount of calories eaten 
above the threshold. The PAP will never be at zero activity 
in mammals because a minimum activity (here called 
“OFF”) is needed to give a PAP output that generates the 
mean rate of aging of each species. This “OFF” aging rate 
would be maintained when there is no food available. 
Shortly after eating, food is digested and absorbed and 
tissue PAP activity would jump in a qualitative leap to the 
“ON” higher output level. When the animal reaches the 
postprandial state and the substrates ingested have been 
fully metabolized, PAP activity will go back to the lower 
"OFF" resting level of aging effector (PAP output) 
activity.  
Further research is sorely needed to clarify whether the 
PAP output is graded or “all-or-none”, because this could 
have important implications concerning which is the 
healthiest way of eating to be recommended for human 
beings. If PAP works qualitatively (ON/OFF) rather than 
gradually, the classical recommendation of the last decade, 
eating 5 times per day, would not be the best. On the 
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contrary, putting all the food in a single early meal, or 
perhaps, in two big meals one at around 15:00 and the 
other at around 20:30, together with a very frugal breakfast 
-as it is typical in Mediterranean countries which are 
among the most long-lived worldwide- would be an 
adequate option. In this way, people would expend most of 
the day (19 hours) fasting (the PAP working in OFF 
position), and their PAP will be turned ON for a few hours 
only once or twice per day. If this were correct, the 
habitude of eating small amounts of food, so typical of 
some western countries, but with high frequency at almost 
every time during the day should be avoided. Food that 
strongly signals to PAP, like simple carbohydrates (sugar) 
or sweetened beverages generating high insulin peaks 
should be specially avoided, while complex carbohydrates 
that are slowly absorbed would lead to much lower insulin 
peaks. High amounts of methionine, an amino acid that 
specifically signals the PAP, could be prevented avoiding 
excessive consumption of meat and restricting the intake 
of total protein to around 0.6 g of protein/Kg of body 
weight per day (0.8 is the current RDA at USA and many 
other countries). 
9.3. Epigenetics, aging and PAP 
A further complication involves interactions within the 
cell nucleus functionally affecting the nuclear gene 
clusters of aging PAP genes. In addition to varying their 
expression in response to cytoplasmic, hormonal, and 
environmental signals, there can be nuclear feed-back 
among these genes due to epigenetic modifications (Figure 
8). Epigenetic changes like DNA methylation, acetylation 
or phosphorylation and histone modifications seem to be 
important factors in aging. Epigenetic marks establish 
changes in gene expression in response to environmental 
stimuli (like the different DRs) and drugs (like rapamycin) 
and can be even part of the PAP itself (162). Some authors 
even support the existence of an "epigenetic clock"(163, 
164). This would be essentially different from the 
"epigenetic drift" during aging which would correspond to 
stochastic changes that will be of small or not interest for 
the control of longevity (164). There is a decrease in 
global DNA methylation during aging, whereas there is an 
increase with aging in local methylation at CpG islands 
and specific promoters (164-166).  
A recent analysis of human body epigenome has found 
widespread tissue-specific differential CG methylation, 
allele-specific methylation and transcription, and the 
unexpected presence of non-CG methylation in almost all 
human tissues which correlates with tissue-specific 
functions (167). Changes in specific histones have been 
also described during aging, including global increases in 
H4K20 trimethylation and H3S10 phosphorylation, and 
decreases in H3K9 and H3K27 trimethylation and H3K9 
acetylation (168), which would contribute to modulate 
aging rate. Such DNA modifications modulate gene 
expression through regulation of chromatin structure, 
which is known to change during aging. Many age-
dependent histone methylations are reversed by both DR 
and rapamycin treatments in mouse brain (169). Histone 
deacetylases like SIRT1, and the mitochondria-specific 
SIRT3 are involved in the decrease in oxidative damage 
and antiaging effects induced by DR in mice (170). 
Interestingly, SIRT3 deacetylates various Complex I 
subunits (171) which could modulate the nearby placed 
sites of mitROSp. It is also of interest that epigenetics 
seems to influence two main effectors of PAP, the 
mitochondria (172-174) and the autophagy system (154). 
10. CONCLUSIONS  
1. Long-lived mammals and birds have species-specific 
low mitochondrial ROS generation rates at complex I, low 
levels of mtDNA oxidative damage, and low fatty acid 
unsaturation degrees in their cellular and mitochondrial 
membranes. After almost two decades of research, the rate 
of mitROSp and the fatty acid unsaturation of cellular 
membranes continue to be the only two known traits 
correlating with animal longevity in the right sense and 
offering a plausible mechanism to cause aging. This is true 
not only concerning MFRTA but also all theories of aging 
in general so far proposed. The close vicinity or even 
contact between the site of ROS generation and mtDNA 
avoids antioxidants to interfere with the ROS produced at 
the mitROS generator relevant for aging, which is situated 
at complex I. This is likely why antioxidants do not modify 
longevity. The ROS-dependent final forms of mtDNA 
damage most relevant for aging –mtDNA deletions, and 
mtDNA fragments inside nDNA- seem finely tuned and 
controlled by the rate of mitROS production of each 
animal species. This significantly contributes to determine 
the species-specific aging rate and longevity.  
2. It is well known that DR also decreases mitROSp 
and FRL at complex I and oxidative damage to mtDNA. 
This is exclusively due to the lower methionine intake 
(MetR) of the animals subjected to DR. Around 50 % of 
the longevity extension effect of DR and PR is due to 
MetR, and seems to increase longevity in part through 
decreases in mitROSp at complex I; the other 50 % effect 
of DR on longevity would act through other mechanisms 
like, perhaps, increased macro-autophagy. Rapamycin, the 
only known drug that consistently increases longevity in 
mammals also decreases mitROSp at complex I and FRL, 
like all the different types of DRs. Interestingly, all the 
four known experimental manipulations that have proven 
to increase mammalian longevity decrease mitROSp at 
complex I, FRL, and mtDNA damage (either 8-oxodG in 
mtDNA, or mtDNA fragments insertion inside nDNA).  
3. The constantly produced mtROS throughout life at a 
different rate in each species leads to the generation of 
oxidative damage in mtDNA (e.g. 8-oxodG) which is 
repaired and can lead to point mutations in the process. 
But mitROS, substances produced by the organism that 
have capacity to break covalent bonds, also generate 
single and double strand breaks in mtDNA. This leads to 
irreversible forms of damage (mutations) like mtDNA 
deletions, and mtDNA fragments which enter the 
chromosomes through the centromeres and accumulate in 
nDNA during aging. The steady-state level of 8-oxodG in 
mtDNA is a marker of the flow of ROS-dependent damage 
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generation and repair through mtDNA. Its measurement is 
a useful marker of the rate of generation of mtDNA 
deletions and mtDNA fragments. Mutations can also arise 
due to processes unrelated to oxidative stress like mtDNA 
replication and repair. However, it is highly unlikely that 
these last mechanisms of damage generation are related to 
longevity, because their random nature can not explain the 
determination of longevity during DRs and in different 
animal species. It has been argued that the types of base 
mutations (transitions or transversions) mainly present in 
mtDNA indicate that they mainly come from mtDNA 
replication and repair. This has been taken as evidence 
against MFRTA. But this applies only to base substitutions 
and does not concern to mitROS-induced DNA strand 
breaks leading to mtDNA large deletions, and to mtDNA 
fragments insertion inside nDNA. When irreversibly 
damaged mtDNA reaches a high threshold level in a cell, 
approaching homoplasmy of mutated mtDNA, 
mitochondrial ATP generation through oxidative 
phosphorylation is decreased to levels great enough to 
contribute to aging. There is no consensus if this classical 
concept of MFRTA (176) can contribute to explain aging 
and longevity. 
 It is now known beyond reasonable doubt that mtDNA 
fragments accumulate during aging inside nDNA in yeast, 
rat liver and brain, and mouse liver (139,147-149), causing 
an increase in chronological aging at least in yeast (147). 
Recent investigations show that such accumulation, as 
well as the increase in complex I mitROSp and FRL with 
age, are fully (100 %) reversed by rapamycin dietary 
treatment in the liver of middle age mice (139). This is 
accompanied by rapamycin-induced strong increases in 
autophagy fully reverting to young levels, and by partial 
reversion of lipofuscin accumulation with age (139). 
Interestingly, recent studies indicate that the mtDNA 
fragments do not enter nDNA randomly. Instead they are 
directed to the centromeres as a main “entry door” to the 
nucleus. From there, they can potentially disseminate to 
other chromosome regions, perhaps being specifically 
directed to nDNA regulatory regions controlling the gene 
clusters of aging (PAP) residing in the cell nucleus (153), 
thus contributing to aging and to accelerate the mortality 
rate at old age. Further research is urgently needed to 
clarify this possibility. Alternatively, and more simply, the 
mtDNA fragments can potentially alter the information 
coded in nDNA. They could be directed specifically to 
structural genes, thus promoting cell malfunction, cell 
death, or cellular malignant transformation, and thus aging 
and cancer. 
4. The low fatty acid unsaturation degree of cellular 
and mitochondrial membranes of long-lived animals leads 
to relatively low rates of endogenous lipid peroxidation in 
vivo, which is, quantitatively, the most destructive 
oxidative stress process to the main different types of 
cellular macromolecules. A low rate of membrane lipid 
peroxidation in long-lived animals also leads to decreases 
in the generation of highly toxic and mutagenic lipid 
peroxidation products like malondialdehyde, 
hydroxynonenal and many others, which can diffuse from 
membrane peroxidized lipids to the cell nucleus. Some of 
these products have the potential to modify DNA, e.g., 
through direct interaction of the carbonyl group of the 
aldehydes with free amino groups in mtDNA or nDNA. 
This would add secondary DNA damage to that primarily 
coming from the complex I mtROS generator relevant for 
aging. There is a paucity of studies concerning lipid 
peroxidation-dependent damage to mtDNA and nDNA 
(175), especially due to technical limitations. They are 
however potentially interesting and should be studied.  
5. DR and MetR also decrease protein oxidation, 
glycoxidation and lipoxidation, perhaps due to the 
decrease in mitROSp at complex I or to an increase in 
protein catabolism during the DRs. Mitochondrial protein 
oxidation-derived modification can also contribute to the 
accumulation of mtDNA mutations, although this 
possibility has also been poorly investigated. 
6. Many different kinds of evidence converge in the 
concept that aerobic tissue cells (both the post-mitotic and 
the mitotic ones) have a Pro-Aging Program (PAP) lying 
inside the cell nucleus, likely composed of hierarquically 
interrelated gene clusters of aging analogously to the Hox 
genes controlling development (153). The PAP is a main 
central part of the Cellular Aging Regulatory System 
(CARS). The large amount of pro-aging genes already 
discovered during the last two decades are highly 
conserved during evolution from yeast and nematodes to 
Drosophila, and mammals, like in the case of the Hox 
genes. The PAP reacts to GH/ insulin/IGF-1 like signaling 
and to cytoplasmic signals like those from AMPK, mTOR, 
and many others, in response to the different 
environmental types of dietary restrictions or drugs like 
rapamycin. The signals entering the nucleus would modify 
different PAP master genes through transcription factors 
like FOXO, TFEB and many others. These master genes 
would then modify the expression of different gene 
clusters of aging mainly constituting the PAP. These 
clusters must be organized in a hierarchical cascade of 
genes interrelated trough transcription factors, enhancers, 
promoters, et cetera. The target genes situated at the lower 
level in such hierarchy would modify the synthesis of 
specific proteins which change the activity level of the 
aging effectors (executors of aging).  
Among PAP target genes some have been already 
identified. These are the ones controlling: i) the synthesis 
of matrix-only complex I domain; ii) delta 5 and 6 
desaturases and elongases in the n-6 and n-3 pathways of 
fatty acid synthesis; iii) many autophagy genes. Some 
signals coming from the environment (the DRs) can by-
pass the nuclear PAP and directly modify the mitochondria 
(or likely other aging effectors) changing their rate of 
mitROSp at complex I.  
7. Among candidate aging effectors in aerobic tissues 
(both mitotic and post-mitotic), three emerge at present: 1) 
Mitochondria (including mitROSp); 2) The degree of fatty 
acid unsaturation (DBI) of cellular membranes; and 3) 
Autophagy. Decreases in the first two effectors slow aging 
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and increase longevity. Clarifying if over-expression of 
autophagy genes increases o not mean and maximum 
longevity over that of normal controls in mice, and if long-
lived animals have higher autophagy activity than short-
lived ones is urgently needed. The rate of mitROSp at 
complex I and the DBI are low in long-lived animals, thus 
correlating with longevity in the right sense. In addition, 
mtROSp at complex I and autophagy respond to the 
environmental pro-longevity signals of the different kinds 
of DRs or rapamycin: mitROSp at complex I is decreased 
and, autophagy is increased, both collaborating in a 
integrated manner to increase longevity.  
8. With so few aging effectors reasonably well known 
up to now (only three) it seems strongly inappropriate the 
pretension of some authors that "MFRTA is dead". Such 
conclusion, heavily repeated by some authors through 
titles of recent articles is largely based either on: a) low 
quality measurements like the use in of unspecific kits to 
estimate oxidative stress in naked mole rats (177,178), and 
lack of stating if the naked mole rats used for the 
measurements were queens (30 years of longevity) or 
soldiers (few years of longevity) (177,178); in the second 
case a high oxidative stress in naked mole rats would 
confirm MFRTA instead of being contradictory with it; or 
b) technically well done experiments but based on 
hypothesis impossible to be correct, especially those 
testing whether over expression of antioxidant enzymes 
could increase longevity (for a, and b see more detailed 
comments on ref. 29). It was well know from the decade of 
1990 on that antioxidants, for various different reasons 
described in sections 2 and 3.4, do not control longevity 
(2,7,10-12,14,17,23,24,29,32,55). The wrong hypothesis 
that "antioxidant enzyme overexpression could increase 
longevity" was necessarily destined to falsification, 
because it was wrongly formulated from the beginning, 
ignoring dozens of previous investigations on the subject. 
Avoiding such overexpression experiments would have 
saved a lot of time and resources as well as reaching 
wrong conclusions highly damaging for gerontology like 
erroneously considering the mitochondrial free radical 
theory "dead". Such mistake would "eliminate" from 
current models one of the two aging effectors changing 
longevity in the DRs or rapamycin treatment, mitROSp, 
leaving autophagy alone to respond to DRs or rapamycin. 
It would "eliminate" precisely the aging effector about 
which more positive evidences are available, including the 
differences in longevity between mammalian and bird 
species. Such pernicious situation for biogerontology 
should be avoided. 
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